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Abstract 
Polypharmacy has been identified as a significant issue in the elderly that leads to an increased 
risk of adverse drug events resulting in increased emergency room visits and falls, leading to 
rising costs to the healthcare system.   Polypharmacy, although poorly defined, is too many 
medications or unnecessary medications, which can be considered a risk and potential burden to 
patients and caregivers.  The purpose of this quality improvement project was to educate and 
empower long-term care (LTC) facility and hospice nurses to recognize polypharmacy and 
utilize the MedStopper® online tool for recommending medications for deprescribing.  
Education was provided to the nursing staff regarding the recognition of polypharmacy and how 
to use the MedStopper® online tool to facilitate medication conversations with the patient, the 
family, and the provider.  The MedStopper® online tool was printed for each patient weekly and 
reviewed with nursing staff in preparation to recommend medications for deprescribing.  
Medication reviews were then conducted each week to evaluate the progression of the project.  
Project progress, written educational articles, and photos were posted at each LTC nursing 
station during weekly rounding by the primary project manager.  At the end of the project, the 
data revealed a decrease in at least one of the seven targeted drug categories for each patient, 
vitamin/supplements, gastrointestinal reflux, statins, anticoagulants, cognitive enhancing, 
antihypertensives, and antihyperglycemics.  Nurses are crucial to assisting the prescriber in 
making excellent medication decisions for all patients and especially those residing in long-term 
care facilities.  Nurses must be educated and empowered to advocate for the medication 
management of their patients.  Collaboration with team members and providers can and should 
be guided with evidence-based tools such as the MedStopper® online tool.   
Keywords: polypharmacy; deprescribing; long-term care (LTC); evidence-based practice 
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Chapter One:  Overview of the Problem of Interest 
 Healthcare providers working with hospice patients residing in long-term care (LTC) 
facilities face issues regarding their number of medications and the need for certain drugs.  
Hospice patients, by Medicare definition, have a life expectancy of fewer than six months, and 
the goal of treatment has transitioned from one of cure and maintenance to one of comfort and 
palliation of symptoms (U.S. Centers for Medicare & Medicaid Services [CMS], 2019).  
However, many end-of-life patients residing in LTC facilities continue to be prescribed 
medications such as statins, anticoagulants, antihyperglycemics, anticoagulants, and antibiotics 
that may not be congruent with the goals of the hospice patient (van Nordenne, Lavrijsen, 
Vissers, & Koopmans, 2014).  In the terminally ill patient, physiologic changes are intensified by 
a changing metabolism, a decline in renal and hepatic functions, and loss of body mass, leaving 
the patient susceptible to harmful side effects and adverse drug reactions (Morin et al., 2017). 
The purpose of this proposed evidence-based practice (EBP) change project was to recognize 
and recommend medication reduction in hospice patients residing in LTC.   
Background Information  
Medications contribute to quality healthcare and quality of life for many patients through 
the prevention and potential cure of disease (Ailabouni, Tordoff, Mangin, & Nishtala, 2017). 
However, the use of medication is not risk-free and may contribute to adverse drug events, 
increased hospitalizations, and decreased quality of life when utilized in the patient at end-of-
life.  Frail hospice patients often have multiple geriatric syndromes, complex diagnoses, and 
chronic long-term conditions for which they have been prescribed medications for long-term use 
and are more vulnerable to medication-related adverse outcomes (Ailabouni et al., 2017).  A 
survey of 307 Registered Nurses (RN)s of a nationally representative sample of LTC facilities 
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showed that 67.4% of nurses agree or strongly agree that deprescribing would be beneficial to 
residents, improve residents’ quality of life, and reduce the time spent administering medications 
(Ailabouni et al., 2017).  
Polypharmacy presents a challenge to nursing staff caring for patients at the end-of-life.  
One definition of polypharmacy is the prescribing of too many medications for one patient 
(Kaufman, 2016).  The definition of what constitutes too many is often considered five or more 
medications. It is common for older adults in the United States, with an estimated 50% of people 
65 years and older taking more than five medications (Reeve et al., 2018).  However, the 
prescribing of medications that do not have current indications or are known to be ineffective, 
unnecessary, or considered duplicate therapy are also polypharmacy and problematic in the 
elderly (Endsley, 2018).    
Patient-centered care means increased patient involvement in health care decision-
making, and many adults report wanting to be very involved in these decisions. Still, many 
physicians report patient resistance or unwillingness to stop taking medications (Reeve et al., 
2018).  The constant advent of new medications, frequent use of preventative treatments, and a 
healthcare system focused on single diagnosis-related treatments contribute to polypharmacy 
(Jokanovic, Tan, Dooley, Kirkpatrick, & Bell, 2015).  Cherubini, Corsonello, and Lattanzio 
(2016) state polypharmacy is caused by the increasing availability of medications, 
multimorbidity, or the occurrence of multiple diseases in the same patient.   
The targeted project site utilizes a national pharmacy vendor. During regular 
benchmarking calls, it was noted that the project site’s average prescriptions per patient were 
higher than that of other hospices of similar size and type.  An internal initiative was undertaken 
to better identify and utilize medications related to the hospice diagnoses, and there was some 
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improvement noted.  However, the project site remained above the benchmark of 10.2 
medications per patient per day, as seen throughout other vendor’s hospice clients.  A drill-down 
of the data revealed that hospice patients residing in LTC facilities continued to have higher than 
average numbers of specific medications.  Discussions between nursing, practitioners, and 
pharmacists led the clinical leadership team to determine that the hospice practitioners had no 
prescribing authority in these facilities; thus, they had been unable to affect the medication 
management plans of that patient population positively.   
The primary project manager met with the administrators of two locally contracted LTC 
facilities and discussed the issue.  The administrators of both facilities agreed that polypharmacy 
was an overall problem in the facilities and agreed that the facility staff does not have the 
education nor the tools to identify or recommend medications for deprescribing.  Nurses are in 
key positions to identify and suggest medications for discontinuation and can determine if the 
initial indication for certain medications is still valid, if medications still have the desired effect, 
and whether prescribed medications still meet the goals of patients (Bergman-Evans, 2013).  As 
a result, this project focused on nursing strategies to impact the problem of polypharmacy. 
Significance of Clinical Problem  
 Polypharmacy has been identified as an issue in the elderly that leads to an increased risk 
of adverse drug events resulting in increased emergency room visits and falls (Jokanovic et al., 
2015).  These events, in turn, lead to rising costs to the healthcare system.  Nearly 50% of the 
respondents to a cross-sectional survey of 307 RNs working in LTC reported spending 4 to 7 
hours completing medication rounds, and 98% of respondents indicated they were aware of the 
common adverse effect associated with medications (Ailabouni et al., 2017).  Overuse and 
misuse of medications in the frail elderly are also associated with a higher incidence of 
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unplanned hospitalizations due to drug-related events or falls.  An estimated $1.75 is spent 
treating medication-related issues for every $1.00 spent on medications (Zullo, Gray, Holmes, & 
Marcum, 2018).  Zullo et al. indicate the cost to the healthcare system is significant as the system 
spends nearly double the amount paid for medications to treat drug-related problems.  
 Currently, there is very little knowledge known about how the majority of drugs impact 
older patients or evidence of their effects.  Most drug trials exclude the frail elderly, cognitively 
impaired, or LTC patient.  Long-term residence is often the most common reason for exclusion 
from a randomized controlled trial (Cherubini et al., 2016).  As death approaches, physiological 
changes increase as evidenced by changing metabolism, impaired hepatic and renal functions, 
and a loss of weight.  These changes shift the way medications are utilized in the body, 
increasing the patient’s vulnerability to harmful and sometimes painful side effects (Morin et al., 
2017). The question of the appropriateness of the medication must be measured against the 
burden of medication therapy and the role of nurses in that decision. 
 Polypharmacy has been associated with increased costs related to drug-related events or 
falls, but inappropriate and unnecessary medication use may waste limited financial resources 
and nursing staff time to administer medications (Kojima et al., 2012).  Kojima et al. conducted a 
project to reduce the medications of LTC facility residents and showed an average reduction in 
the medication costs of $30.71 per patient per month. The project resulted in a decrease in the 
nursing cost of $22.43 per patient per month.  The nursing cost was based on an average hourly 
rate of $23.10 based on current labor statistics.  These results are based upon an average of 3.0 
recommendations to deprescribe per patient.  It is estimated that for each oral medication added 
to a patient’s oral medication pass it takes an additional 45 seconds; thus, the cost of adding that 
drug can be between $7 and $21/day per patients; even if the medications are passed at the same 
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time (Pruskowski, Zarowitz, & Handler, 2018). The reduction of medications in the LTC patient 
has the potential to decrease overall costs associated with drug-related events as well as costs 
associated with nursing administration time.   
Question Guiding Inquiry (PICO)  
 Evidence-based practice uses the most current evidence available and begins with the 
consideration of a well-organized PICO question.  PICO is an acronym that assists the individual 
to identify the population or participants of interest (P), intervention needed for practice (I), 
comparisons  (C) of interventions to decide the best intervention for the practice, and the 
outcomes (O) needed to measure the intervention (Grove, Gray, & Burns, 2015). The clinical 
question guiding this inquiry asks; “For nurses in an LTC setting, does the implementation of 
polypharmacy education and use of the MedStopper® tool impact reducing the polypharmacy 
for hospice patients?”  
Population.  The target population consisted of hospice and LTC nurses.  The hospice 
and LTC nurses consisted of a mixture of both RNs and licensed practical nurses (LPN). 
Participant nurses were 18 years of age or older, consisted of both genders and included all 
ethnicities.  These nurses were caring for hospice patients residing in the targeted project site 
LTC facilities.   
Intervention.  The targeted intervention consisted of two parts.  First, the utilization of 
the online tool MedStopper® (i.e., http://MedStopper®.com) which focuses on identifying the 
medications appropriate for deprescribing designed with the frail elderly patient in mind and 
returns information on whether the medication is likely to provide symptom management, reduce 
future illness risk, or increase the risk for future harm (Zullo et al., 2018).  Polypharmacy can be 
addressed by the empowerment of nurses through education regarding the identification of 
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polypharmacy and how to recommend deprescribing to the patient’s provider (Ailabouni et al., 
2017).  When nurses are educated, they are better advocates for identifying those medications 
that may be stopped based on their assessment of patient’s behaviors and function (Bergman-
Evans, 2013).  
Comparison.  There is no comparison group. The MedStopper® tool and polypharmacy 
education are designed to empower nurses to be more proactive in the medication management 
of patients.  The primary project manager reviewed medications in the targeted drug classes to 
monitor for deprescribing in such classes.   
Outcomes.  The first outcome was to increase hospice and LTC nurse’s knowledge 
regarding polypharmacy, identifying medications that may be stopped, and how to recommend 
deprescribing to the provider.  The aim of medications at end-of-life should be based on patient 
comfort (van Nordenne et al., 2014).  Polypharmacy is often fed by the addition of symptom 
management medications, the retention of long-term preventive medications that may no longer 
be of any benefit, and a lack of evidence-based guidelines for deprescribing (Morin et al., 2017). 
The second outcome was to promote the hospice nurse utilization of the MedStopper® 
tool in discussing polypharmacy with the LTC nurse.  The aim was to utilize the MedStopper® 
report as a way to recognize polypharmacy and formulate a recommendation for potential 
deprescribing of medications to the provider. Hospice nurses were provided the MedStopper® 
report within two working days of project implementation or new hospice admission, and weekly 
during project implementation. Hospice nurses were to discuss the report with the nurse at the 
LTC facility at the next routine nursing visit. This discussion was documented in the hospice 
medical record which were reviewed weekly for compliance.   
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The third outcome was to decrease polypharmacy in the hospice patient in the LTC 
setting in the drug categories of vitamin/supplements, statins, anticoagulants, cognitive 
enhancing, antihypertensives, and antihyperglycemics.  Over 50% of nurses surveyed agreed that 
reducing medications in the LTC patient would improve medication adherence, improve 
resident’s quality of life, and reduce the time spent on medication administration (Ailabouni et 
al., 2017).  Polypharmacy is also associated with increased drug-related events such as drug-drug 
interactions, adverse drug events, falls, re-hospitalization, and mortality (Cheribini et al., 2016).  
Summary 
 Polypharmacy in the hospice patient in an LTC facility affects not only the hospice 
patient but also the providers of that care, and the healthcare system as a whole.  The patient is 
negatively affected as more and more medications lead to increased risk of adverse events, 
increased the possibility of falls, and increased risk of emergency department visits (Jokanovic et 
al., 2015).  The nursing staff is affected negatively as increased medications lead to an increased 
workload for staff administering these medications.  Nurses are critical components in caring for 
hospice patients in LTC facilities and are significant influences on prescribing and deprescribing 
(Ailabouni et al., 2017).  Education, empowerment, and the provision of evidence-based, easy to 
use tools should be used by nurses to provide evidence and empower them to recommend 
medications to discontinue. The literature is rich with the need to reduce polypharmacy in the 
frail elderly patient to improve quality of life, reduce adverse outcomes and reduce the burden on 
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Chapter Two:  Review of the Literature  
Polypharmacy in the hospice patient residing in the long-term care (LTC) facility has 
many adverse consequences (Endsley, 2018).  Nurses need to be empowered to have a greater 
understanding of identifying polypharmacy and recommending deprescribing to providers 
(Kaufman, 2016). Empowering nurses requires access to education and tools to guide decision 
making.  To guide this evidence-based practice (EBP) change project, a comprehensive literature 
search was conducted to determine evidence-based interventions for understanding and 
identifying polypharmacy, its risks, and tools to utilize in decision-making.  This chapter details 
the methodology and findings of this literature review.   
Methodology  
Sampling strategies.  A comprehensive electronic literature search was performed using 
the following databases: PubMed; Cumulative Index to Nursing and Allied Health Literature 
(CINAHL); Medline via Ovid; and Google Scholar. Eriksen and Frandsen (2018) state the 
Population, Intervention, Comparison, and Outcome (PICO) model is the most widely used 
modeling for developing search terms for researching clinical questions; thus, the keywords used 
in the search were: polypharmacy; polymedicine; nurse; nursing; deprescribing; medication; 
elderly; older; frail; long-term care (LTC); nursing home; reducing cost; end-of-life; 
inappropriate medication; Rogers’ theory; outcomes; and interventions. Keywords were 
combined using the Boolean operator “AND” to increase responses.  The search was initially 
conducted without any limitations; however, the return was too vast.  Limits were then applied to 
five and ten years.  An exception was made for the search of Everett Rogers’ 1983 work on 
planned change, which serves as the theoretical framework for the project.  Limits placed on the 
search included: English only; clinical journals; nursing journals; pharmacy journals; academic 
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journals; and news articles.  Literature was selected for inclusion based on levels of research 
evidence as presented by Stevens and Clutter (2007).  The evidence rating pyramid is presented 
as Level I – Evidence Summaries; Level II – Experimental Research Studies; Level III – Non-
experimental Studies; and Level IV – Qualitative Studies, Expert Opinion, Theory, and Basic 
Science (Melnyk & Fineout-Overhold, 2015).   
Evaluation criteria. Literature was selected for inclusion based on the relevance to the 
defined PICO question and the intervention of education regarding polypharmacy in patients 
residing in the LTC facility.  Critical assessments of the studies were conducted by asking: Do 
the results support the proposed intervention and plan?; Are the results understandable?; and Are 
the results consistent with other valid studies?  Studies were selected to identify and evaluate the 
clinical problem of polypharmacy and its relevance to patients at the end-of-life.  Selected 
literature provided background and significance of the problem and support of the interventions 
to utilize the MedStopper® tool and polypharmacy education for the nurses involved in the care 
to hospice patients residing in a nursing home.  The assessment of the studies selected for 
inclusion from the review of literature is provided in Appendix A.   
Literature Review Findings 
 Ailabouni, Tordoff, Mangin, and Nishtala (2017) conducted a cross-sectional survey of 
307 Registered Nurses (RNs) who work in residential aged care facilities. A 48-question 
questionnaire was used, including closed- and open-ended questions.  The RNs were asked 
questions about each stage of the medication use process, a) prescribing; b) medication chart 
review; c) receiving dispensed medications; d) administration; and e) monitoring.  Nurses 
concern their opinions on deprescribing and whether the inclusion of a clinical pharmacist on the 
team would be beneficial. Ninety-one questionnaires were received; a response rate of 29.6%.  
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Approximately one-half of respondents (50.5%) stated they sometimes suggest reducing or 
stopping medications.  When asked about medication chart reviews, 97.8% report that this is 
completed for residents within three months.  RNs (47.3%) believed that the providers 
sometimes stop medications after this review, but 8.8% of RNs report that providers rarely stop 
medications after this review.  Barriers to stopping or reducing medications were cited as time 
constraints, lack of adequate reimbursement, pressure from specialty providers, and 
patient/family wishes.  Ailabouni et al. concluded RNs are key influencers of prescribing and by 
empowering RNs through education on deprescribing and how to successfully achieve it is a way 
to overcome this issue.  Ailabouni et al. also suggested easy to use references and drug-specific 
guidelines be used to provide evidence as to why it would be appropriate to stop certain 
medications they believe are no longer needed by the patient.   
Jokanovic, Tan, Dooley, Kirkpatrick, and Bell (2015) conducted a study to investigate the 
prevalence of and factors associated with polypharmacy in LTC facilities.  Articles were 
searched to locate studies published between January 2000 and September 2014.  Forty-four 
studies were included in the review.  Jokanovic et al. found that up to 91% of LTC residents 
were prescribed more than five medications, and 65% were prescribed more than ten 
medications.  The study also found that there were positive associations for recent hospital 
discharge.  Jokanovic et al. concluded that the prevalence of polypharmacy in LTCs is high, but 
there is great variability between facilities, geographical locations, and the definitions of 
polypharmacy being used.  Jokanovic et al. cite a need for the use of consistent definitions of 
polypharmacy in the literature as this causes difficulty in drawing firm conclusions.    
Kojima et al. (2012) conducted a quality improvement study at a 180-bed LTC facility.  
Of the 160 residents at the facility at the time of the study, 74 were identified as having 
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polypharmacy as defined by the Minimum Data Set criteria of nine or more medications.  This 
definition supports Jokanovic et al.’s (2015) recommendation that there is a lack of consistent 
definition for polypharmacy as this study does not include patients having less than nine 
medications prescribed.  This project was designed to look at cost savings after a simple 
physician intervention on polypharmacy.  Kojima et al.’s intervention were two-fold. First, 
medication lists were generated, and physicians then generated a list of recommendations to 
continue, to taper, or to discontinue.  The second step was a review of all medications to be 
continued using an on-line drug-drug program to assess for contradictions.  The second set of 
recommendations were then generated for each patient.  The recommendations were then shared 
with the LTC and the patient’s primary physician for final orders.  A total of 151 
recommendations were made with an average of 3.0 recommendations per patient.  The primary 
physician accepted 86% of the recommendations.  The mean number of medications per patient 
decreased from 16.6 to 15.5.  These changes led to a medication savings of $30.71 per patient 
per month and a savings of $22.43 per patient per month in nursing costs.  Kojima et al. point out 
that the project utilized “readily available quickly accessible tools” (p. 5). Kojima et al. state that 
it is important to make individualized decisions with clinical judgment based on the patient’s 
prognosis and goals of care.   
Morin et al. (2017) conducted a longitudinal cohort study in Sweden on the burden of 
medications in older adults at end-of-life.  Morin et al. reviewed 511,843 adults over 65 years of 
age who died in Sweden between 2007 and 2013. The authors reconstructed the patient’s 
medication history over the last 12 months of life.  Of the patients in the study, it was found that 
over 51% had more than five diagnosed chronic conditions including ischemic heart disease, 
hypertension, congestive heart disease, cancer, atrial fibrillation, and cerebrovascular disease.  
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Morin et al. discovered that between the first and final months of life the percentage of patients 
prescribed greater than ten drugs rose from 30.3% to 47.2% with the mean rising from 7.6 drugs 
to 9.6 drugs.  Morin et al. also found that those patients living in LTC facilities had a greater 
number of drugs prescribed.  This trend remained consistent even after excluding analgesics 
from the total medication count.  Morin et al. found that the most commonly prescribed 
medications were antithrombotic agents, diuretics, analgesics, psychotics, and beta-blocking 
agents.  Morin et al. had two main findings.  First, almost half of the patients had an increase in 
drugs in their last year of life.  Second, that polypharmacy is fueled not only by an increase in 
symptom management medications but by the frequent continuation of long-term preventative 
treatments and disease-targeted drugs.  Morin et al. recommend the withdrawal of medications 
should be embedded into clinical guidelines, in the same manner, the initiation of medications is 
incorporated.  
Pruskowski, Zarowitz, and Handler (2018) surveyed 637 attendees of the 2017 American 
Medical Directors Association-The Society for Post-Acute and Long-term Care Medicine 
Annual Conference.  The goal of the study was to describe the current utilization of 
deprescribing, and perceptions of a deprescribing program in nursing facilities to decrease 
potentially inappropriate medications.  Of note, 88% of the respondents were physicians.  The 
five-page survey was aimed at 1) Explore the familiarity of deprescribing; 2) Investigate the 
perceived utility of deprescribing, and 3) Describe the desired components of a deprescribing 
program. The survey asked about barriers to deprescribing, and questions were asked regarding a 
case study.  Respondents were also asked to rate the desired components of a successful nursing 
facility deprescribing program.  Of respondents, 96% stated they were at least somewhat familiar 
with the term deprescribing with 97% reporting previous experience with deprescribing in the 
REDUCING MEDICATION USE 23 
   
 
LTC facility; however, only 74% stated that deprescribing was successful.  The respondents 
agreed to a lesser degree deprescribing programs should target certain medications used for 
comorbid diseases over those for symptom management.  Those respondents felt the priority 
should be over “low-hanging fruit” versus “high risk” medications.  The response to prioritize 
“low hanging fruit” is in opposition to Morin et al.’s (2017) statement, “the clinical benefit of 
treatment drugs aiming at preventing diseases during the final month of life is at the least very 
questionable.” (pg. 934).  Morin et al. (2017) contend physicians should discontinue drugs that 
may be appropriate but whose possible harms may outweigh the potential benefits before death 
occurs.  Medications with harm would not always be the “low-hanging fruit” as these 
medications may require careful discussion and consideration.  Pruskowski et al. (2018) did find 
a surprising statement that indicated the respondents believed a pharmacist should lead a 
deprescribing program.  Pruskowski et al. did state that one limitation of the study was the 
sampling method and potential bias in the respondent group as most were physicians and may 
not represent the attitudes of the nursing facilities interdisciplinary team.   
van Nordenne, Lavrijsen, Vissers, and Koopmans (2014) conducted an integrative review 
on decision making about medication changes for comorbid diseases at the end-of-life.  The 
authors selected 67 papers published between 1995 and 2013 for review.  van Nordenne et al. 
looked at different medication groups as they reviewed literature.  Those groups included statins, 
antihypertensives, anticoagulants, antihyperglycemic agents, and antimicrobials.  Much like the 
Morin et al. (2017) study, van Nordennen et al. (2014) found certain medication groups highly 
prescribed in patients with polypharmacy.  van Nordennen et al. make several 
recommendations/statements based on the review: 1) Continuation of statins has no benefit; 2) 
Strict blood pressure control has no place at the end of life; 3) The use of anticoagulants can pose 
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serious risks to patients at end-of-life due to changes in drug therapy and potential drug-drug 
interactions; 4) Symptom management of diabetes means glucose checks are only indicated 
when the patient is symptomatic and dietary changes at end-of-life should be considered when 
deciding to continue antihyperglycemic medications, and 5) The aim of antibiotics at the end-of-
life should only be symptom management.  van Nordenne et al. conclude that all medications 
used for comorbid conditions be critically evaluated at the end-of-life.  Medications that do not 
benefit the patient or alleviate symptoms should be stopped.   
Reeve et al. (2018) studied the results of round six of the 2016 National Health and 
Aging Trends Study (NHATS), a national study of Medicare beneficiaries 65 years and older.  
The sample represents approximately 33.4 million Medicare beneficiaries.  The key question 
reviewed for this study was, “What are the attitudes of older Americans toward deprescribing?” 
(Reeve et al., 2018, p. E2).  Reeve et al. state that patient engagement in health care decision 
making is central in patient-centered care and physicians report patient resistance to the 
discontinuation of medications as one of the main factors that prevent deprescribing.  The study 
relied on responses of the NHATS Medication Attitudes model, which was administered to a 
random sample of one-third of total respondents.  The response rate was 94.8%.  The study 
showed 92% of respondents agreed or strongly agreed they would be willing to stop one or more 
medications if their physician said it was possible.  Two-thirds stated they would like to reduce 
the number of medications they are taking, and nearly half (42.7%) stated they felt they were 
taking a large number of medications.  The respondents were asked to select a maximum number 
of pills they would be comfortable taking, and 51.9% chose four pills.  These results suggest that 
providers can be reassured about addressing the subject of deprescribing with their older patients.  
Reeve et al. note that increasing public awareness about the discontinuation of medications is a 
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needed step toward changing the culture around prescribing, which encourages continuing 
medications while adding more.   
Zullo, Gray, Holmes, and Marcum (2018) reviewed strategies for screening for 
medication appropriateness in older adults.  The objectives were to describe the impact of 
medication inappropriateness on health outcomes, examine practical ways to screen for 
medication appropriateness, highlight gaps in knowledge, and to summarize clinical strategies to 
screen for medication appropriateness.  Zullo et al. recommend the incorporation of tools into a 
daily workflow that provides oversight for medication screening.  MedStopper® was one tool 
suggested by the authors due to its ease of use and intuitiveness. However, it is noted that no 
studies have confirmed that the use of a tool will improve the screening process for medication 
appropriateness.  Screening has barriers in the nursing home setting due to low physician 
involvement and high staff turnover.  Another significant barrier noted is the absence of evidence 
about the outcomes of medication use in the frail elderly.  Zullo et al. suggest the following 
strategies for improving the medication screening process: 1) Use a team approach to ensure an 
accurate medical problem and medication lists; 2) Eliminate unnecessary medications by 
considering the risk/benefit profile of medications regularly; 3) Identify potentially inappropriate 
medications and consider dose reduction or discontinuation; 4) Identify conditions not treated 
and document the reasons why; 5) Remember that many clinically necessary medications can be 
high risk in particular older adults such as anticoagulants and glucose-lowering agents; 6) Pay 
close attention to periods when the patient is at high-risk such as transitions of care; and 7) 
Attention should be given to the patient’s preferences and goals of care.  Zullo et al. 
acknowledge screening efforts may appear daunting, but a focused, team-based approach can 
help providers gain momentum and improve medication safety.   
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Endsley (2018) wrote a four-part process for deprescribing medications.  Endsley 
describes a straightforward process including: 1) Review all current medications, including all 
supplements and vitamins, documenting any side effects the patient may be having as a result of 
medication use; 2) Identify inappropriate, unneeded, or harmful medications using aids such as 
the Anticholinergic Burden Calculator, the Beers List from the American Geriatric Society, or 
the website Deprescribing.org developed by a team of physicians and pharmacists; 3) Plan 
deprescribing with the patient to address their concerns about their conditions worsening or 
contradicting other physicians; and 4) Regularly rereview medications as tapering or 
discontinuing medications may need close monitoring.  Endsley states that deprescribing is 
necessary in a world in which patients often take multiple medications prescribed by multiple 
providers who do not directly communicate with each other.   
Kaufman (2016) examined the challenges of polypharmacy for nurses in which the author 
refers to problems including: 1) Appropriate polypharmacy when medications are prescribed to 
address unattainable objectives and adverse drug events are present; 2) Inappropriate 
polypharmacy in which the risks of drug treatment outweigh the benefits or in cases when 
medications are prescribed to treat the side effects of other medications causing a prescribing 
cascade; 3) Drug-drug interactions as is common when single disease-specific guidelines are 
utilized for medication prescribing in patients with multiple comorbidities, thus leading to 
polypharmacy with potentially harmful outcomes; and 4) Adverse drug reactions such as postural 
hypotension due to antihypertensive use.  Kaufman (2016) expressly points out that older 
patients are often excluded from clinical trials, and aging affects the way drugs are metabolized 
and excreted from the body.  These physical changes have the potential to impair physical or 
cognitive functioning as well as causing an increased risk for falls, or malnourishment due to 
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appetite changes.  Kaufman (2016) states that medication review is an opportunity to address 
deprescribing to use medications more safely.   
Bergman-Evans (2013) developed an evidence-based practice guideline to improve the 
medication management of older clients living in LTC facilities.  The guideline was developed 
for nurse practitioners, but Bergman-Evans states it can also be utilized by other members of the 
interdisciplinary team, including nurses, pharmacists, physicians, and physician assistants.  
Bergman-Evans discussed four outcomes, including maintaining functional status, decreasing 
polypharmacy, avoiding adverse drug reactions, and decreasing inappropriate prescribing.  The 
author states that polypharmacy is a significant burden and brings with it a risk for error.  
Bergman-Evans report that a nurse may pass medications to 15-30 patients and complete the 
administration within one hour of the administration time, all while coping with frequent 
interruptions. This task puts the nurse in a critical position to advocate for identifying 
medications for discontinuation or reductions based on the patient’s condition.  By recognizing 
whether the original indication for the drug is still valid or if the drug has the desired effect, the 
nurse can assist in making decisions about whether the cost of the drug and burden is 
worthwhile.  Like Endsley (2018) and Zullo et al. (2018), Bergman-Evans (2013) suggests that 
nurses need good resources for identifying inappropriate medications and recommend current 
drug guides, references, and pharmacists available to consult with regarding rationale, risks, and 
benefits of recommending changing or deprescribing medications.  Bergman-Evans states that 
while medications can be beneficial, they can contribute to problems and the use of evidence-
based guidelines should be a priority for nurses in the LTC practice.   
Cherubini, Corsonello, and Lattanzio (2016) wrote an editorial regarding how to move 
forward in addressing polypharmacy in the nursing home resident.  Cherubini et al. point out that 
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the majority of drugs has never been tested in the old, disabled, cognitively impaired adult.  
These patients are excluded from clinical trials and are an extremely vulnerable population with 
increased sensitivity to adverse drug events due to aging, multiple comorbidities, and disability.  
Adverse events in this population are associated with negative outcomes such as falls, delirium, 
and decline in their ability to perform activities of daily living.  Cherubini et al. also state that 
many LTC patients have reached the terminal phase of their lives when all therapy should be 
reviewed as to its clinical benefit.  Medication issues are attributed to highly complex conditions, 
low physician involvement in daily care, high rates of staff turnover, and frequent transitions of 
care such as when a patient is hospitalized.  Cherubini et al. cite that the most studied 
intervention to improve medication management in nursing home patients is education with 
some improvement noted.  Cherubini et al. also point out that multidisciplinary team meetings 
have been studied and, in most cases, led to significant effects on prescribing habits.  Cherubini 
et al. recommend that there are potential benefits of implementing a physician-led intervention 
that included promoting greater involvement of the nursing staff.   
Limitations of the Literature Review Process  
 The literature is rich with the need to reduce polypharmacy in the elderly patient to 
improve quality of life, reduce adverse outcomes, and reduce the burden on the patient, the 
nursing staff, and the healthcare system.  Michael Woodward (2003) is attributed for first coining 
the term “deprescribing” in an English journal article.  The concept of pharmacy and the 
reduction of medications in the elderly could still be considered in its infancy.  Thus, literature 
addressing the issue are found primarily after 2010.  This interest appears to correlate with the 
aging of the baby boomer generation; as this generation has aged during the prevalence of 
diagnosed multimorbidity, the use of evidence-based, disease-specific guidelines, and the focus 
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on patient-centered care in which the patient has greater access to information regarding 
medications and their availability. Other considerations for selection was the infrequent inference 
that nursing and the interdisciplinary team had a role to play in the process of deprescribing; 
however, most articles were written with the responsibility left to the physician or prescribing 
provider.  Rogers’ (1983) Theory of Planned Change was evident, though not stated, through the 
selections as the selections acknowledged a problem exists, sought to create interest in solving 
the problem by identifying the adverse effects of polypharmacy, sought to focus on literature that 
supported change, recommended development and implementation of programs to change, and 
suggest the adaption of interdisciplinary models to affect organization-wide change. Other 
limitations were the inconsistent definition of the term polypharmacy, small sample sizes, and no 
randomized controlled trials regarding polypharmacy in the elderly.   
Discussion  
Conclusion of findings. The context of this literature review was based on medical and 
nursing articles focused on the concept of polypharmacy in the elderly population.  Most 
evidence focused on the definition of the concept, the identification of the polypharmacy, and a 
limited focus on the strategies to overcome the issue. Rogers’ (1983) Theory of Planned Change 
explains the model needed for change, including awareness, interest, and adoption.  The research 
discovered and expounded on an awareness that polypharmacy is a problematic issue with 
elderly, frail patients living in LTC facilities.  Articles in the review indicate that the interest in 
the problem is one that affects not only the patient but LTC staff such as physicians, nurses, and 
pharmacists. Studies that acknowledge this interdisciplinary problem also acknowledge the 
solution is multidisciplinary as well.  As such, the literature supports the implementation of 
education of polypharmacy and its effects, the implementation of an evidence-based, easy to 
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access and use tool for nursing staff as the nursing staff is considered key to the identification of 
polypharmacy and advocates of the patient to the provider.  The literature supports a team-based 
approach to overcoming the problem of polypharmacy.   
Advantages and disadvantages of findings.  Advantages of the literature evidence 
include strong support of the identification of polypharmacy with a multidisciplinary team 
approach with the nursing staff being acknowledged as crucial stakeholders as nursing is the 
primary provider of daily care as well as the staff delegated to the administration of all 
medications.  Nurses can determine if medications are still valid based on the patient’s condition, 
are having the desired effect based on the condition of the patient and are causing adverse events 
to the patient (Bergman-Evans, 2013).  By educating and empowering nurses to identify and 
recommend deprescribing to providers, better decisions can be made about the burden to the 
patient and the cost burden to the healthcare system.  
Disadvantages of the literature evidence are that limited evidence is available to support 
the outcomes of deprescribing of medications.  Most clinical trials and qualitative studies 
exclude the hospice and LTC patient being reviewed for this project.  Thus, there are little in the 
form of guidelines that address the deprescribing of medications in patients with multimorbidity, 
advanced age, and limited prognosis.  The recommendations focus mostly on the identification 
of high numbers of medications and the events that may be related to the medications or the 
prescribing cascade itself.  There are limited studies that focus on specific medication groups that 
can be focused on, and very few studies that recommend evidence-based tools to assist the 
healthcare team in these decisions.    
Utilization of findings in practice.  The education implementation of this project was 
two-fold; first, an education program and training directed to the hospice nurses to teach those 
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nurses how to identify polypharmacy and its risks, utilize MedStopper® and make deprescribing 
recommendations. Second intervention will be directed toward the LTC nurses caring for 
hospice patients residing in LTC to teach them to identify polypharmacy and its risks, utilize 
MedStopper® and make deprescribing recommendations.  This education the potential to reduce 
inappropriate and unnecessary medications in this population.  Education and the utilization of a 
simple to use tool has been the most studied intervention and has been shown to have positive 
effects on polypharmacy (Cherubini et al., 2016).  The inclusion of the interdisciplinary team 
also has the potential to have a positive impact on deprescribing habits as nurses are the 
professional caregiver in contact with the patient daily.  By educating and empowering nurses to 
identify and make recommendations on medication management to the provider, nurses can be a 
change agent and advocate for the patient.  The nurse’s role is key to the effectiveness of 
ensuring appropriate medication management for the frail hospice patient in the LTC setting.   
Summary  
 In summary, there is evidence that supports the implementation of an education program 
including the use of an on-line tool for hospice and LTC nurses caring for hospice patients in the 
LTC setting.  This education can empower nurses to identify polypharmacy and recommend 
medications for deprescribing to the provider of the patients.  The nurses may face barriers to 
deprescribing from the providers and patients and families; however, with proper education and 
support, better decisions can be made regarding the medication management in these patients.  
Using Rogers’ (1983) Theory of Planned Change, nurses, patients, family members, and 
providers can become more aware of the safety problems and cost issues caused by increased 
numbers of medications and the continuation of unnecessary/inappropriate medications.  By 
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understanding the problems that result from polypharmacy, interest can grow to solve the 
problem and thus, organizational change can occur.   
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Chapter Three:  Theory and Concept Model for Evidence-based Practice  
According to Grove, Gray, and Burns (2015), theories are the ideas of science, a set of 
concepts and statements presenting a perspective of experience.  Concepts are the words that 
describe an idea or event and give it a separate identity or meaning.  Theory is vital to research 
and research is, in turn, vital to promoting evidence-based practice (EBP) change.  The benefits 
of EBP change are improved outcomes for patients, providers of care, and the healthcare system 
as EBP promotes quality, cost-effective care.  However, there are barriers to EBP, such as a lack 
of research regarding the effectiveness of many nursing interventions.  Doctor of Nursing 
Practice (DNP) prepared nurses are in key positions to promote such research and change in 
healthcare settings.  Because EBP is a phenomenon requiring the synthesis of research with 
clinical expertise and patient values, the DNP prepared nurse is positioned to promote this 
change.  If quality healthcare is to survive, nursing must change based on research and expertise.  
This chapter analyzes the concept of polypharmacy in the context of the nurse’s ability to reduce 
inappropriate and unnecessary medications through the identification and recommendation of 
deprescribing to the provider.   
Concept Analysis  
 According to Avant and Walker (as cited in McEwen & Wills, 2019), the reason for 
analyzing a concept is to clarify the meanings of terms and to define such terms in order for the 
author and reader to share a common language.  Avant and Walker’s steps include deciding on 
the purpose of the analysis and identifying the potential uses of the concepts.  The analysis then 
determines the defining attributes, the identification of cases, the identification of the precedent, 
and the consequence of the concept. The concept being evaluated for this project is 
REDUCING MEDICATION USE 34 
   
 
polypharmacy.  Upon examination of the literature, it was found that there was not a consistent 
definition of polypharmacy.  
For this project, it was essential to decide the most appropriate definition for analysis.  
Pharmacist William Simonson (2015) stated that the “variety of definitions of ‘polypharmacy’ is 
really quite remarkable.” (p. 467).  Polypharmacy is a term used to describe the prescribing of 
too many medications, the wrong medication for a diagnosis, the use of medications with drug-
drug interactions, the prescribing of inappropriate medications or a patient utilizing too many 
pharmacies for obtaining medications (Gillette, Prunty, Wolcott, & Broedel-Zaugg, 2015).  The 
fact there is no single definition of polypharmacy makes it difficult to identify and offers a 
significant challenge for healthcare to solve.  According to Gillette et al., (2015), the term has 
been defined in at least 24 distinct ways, causing confusion among researchers, educators, 
clinicians, and students.    However, Simonson (2015), argued in his commentary that the term 
itself is a misnomer and that the issue is not the number of medications but rather the number of 
unnecessary medications ordered. 
The literature has yet to develop a firm definition of what polypharmacy is or what it is 
not.  There are no tools to measure whether medication use is excessive, nor which medications 
should be discontinued.  Regardless of the definition, the research is clear that polypharmacy in 
each form leads to or contributes to medication-related problems due to drug-drug interactions 
and side effects (van Nordenne et al., 2014).  Quality of life issues related to the side effects of 
medications such as dysphagia or loss of appetite are also noted in the literature (van Nordenne 
et al., 2014).  Zullo, et al. reflect that for each dollar spent on medications there is $1.75 spent to 
treat drug-related problems which result in cost concerns in an already cost-conscious healthcare 
system (Zullo, et al, 2018). 
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Theoretical Framework  
 McEwen and Wills (2019) define a theoretical framework as a set of related concepts that 
provide a mental image of a phenomenon.  A framework supports the concept which begins as 
just an idea or thought.  Through the use of a framework, it was possible to frame the clinical 
problem and work through the problem.  It is this work that has the potential to lead to a change 
in practice.   
Everett Rogers’ (1983) Theory of Planned Change detailed in the book, Diffusion of 
Innovations, served as the theoretical framework for the change that was necessary for a nurse 
working with the dying patient to accept and utilize the knowledge needed to identify and 
recommend to the providers and the patient.  Rogers defines diffusion as a process where 
innovation is communicated to members of a system or organization over time.  Rogers further 
defines communication as a process in which the members share information in order to reach a 
mutual understanding.  Rogers also explains that innovation is the perception of a new idea or 
practice.  However, the “newness” may be interpreted by the new way an individual or 
organization perceives the innovation and the willingness to adopt or reject the idea.  So, if the 
individual or organization is somewhat aware of the innovation and has rejected it, there is still 
an opportunity to renew the interest and persuade the attitude to change.  
Rogers’ (1983) Theory of Planned Change specifically identifies the steps necessary for 
the “innovation-decision process” (p.20).  Rogers’ outlines five steps the learner progresses 
through as they decide whether or not to make a change: knowledge, persuasion, decision, 
implementation, and confirmation. During the project, the nurse must first acknowledge that the 
problem exists and have some basic understanding of the problem to be solved.  The nurse must 
then be persuaded to gain an interest in solving the problem.  It is during the persuasion period 
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that the nurse will develop a favorable or unfavorable attitude toward potential solutions.  If the 
nurse adopts a favorable attitude, Rogers’ theory indicates the next step is the implementation 
phase where the individual takes actions to solve the issue. The final step in change is a period of 
confirmation during which time the individual will seek reinforcement and decide whether the 
change was successful.   
Rogers’ (1983) also classified those who adopted the idea into five adopter categories.  
First are the innovators who are those who are daring and risk-takers.  This group has the ability 
to apply technical knowledge and understand the innovation.  This group may not be well 
respected by the others in the group but are important as they produce a flow of new ideas into 
the implementation.  Roger’s then identifies early adopters as those individuals others in the 
group will look to before trying a new idea.  This group is well respected by their peers and has 
the highest degree of lay leadership of the group.  Rogers’ third group is the early majority.  This 
segment makes up about one-third of the total group and while not the leaders they are very 
interactive with their peers.  They tend to adopt new ideas just before the average team member.  
Then there is the late majority who are the skeptics of the group. They make up another one-third 
of the overall group.  The late majority may adopt the change due to peer pressure but are 
cautious and seem to need for any uncertainty to be removed before they will fully adopt the 
change.  Then there are the laggards who are the last to accept change.  They tend to be sure 
there is no reason to change as change in the past has been unsuccessful.  This group does not 
have any internal leadership and does not communicate well within the team.  The term laggard 
is not intended to be negative simply that they come to adoption late due to their past 
experiences.   
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Application to practice change. Wright, Scott, Buck, and Bhattacharya (2019) state that 
regardless of the nurse’s ability to prescribe medications, they are involved in most aspects of 
medication administration and education.  In this role, the nurse has the opportunity to discuss 
the patient’s attitudes toward the medication they take.  Nurses have insights into the barriers 
faced with polypharmacy and have the training to have skilled communications within a shared 
decision-making model.  By understanding the opportunities to improve quality of life, reduce 
drug events, and reduce costs, the nurse has a vital role in the deprescribing process.   
By using Rogers’ (1983) Theory of Planned Change, the nurse can not only move 
through the steps of change themselves as described previously but also walk with the patient 
and the prescriber through the steps as described.  The nurse can acquire the knowledge 
necessary to recognize polypharmacy and educate the patient about the possibility of reducing 
some of their medications and use communication skills to persuade the patient to accept the 
deprescribing of medication.  At this point, the nurse has the opportunity to share this knowledge 
with the prescriber and persuade the prescriber to consider the discontinuation of a medication 
that may no longer be appropriate, may no longer be effective or adding to a prescribing cascade.  
Once a decision has been made by both the prescriber and the patient, the nurse’s role is to 
implement that change and monitor the patient’s physical responses and report to the prescriber.  
At that point, the decision to de-prescribe can be confirmed as either positive or negative, and a 
determination to continue without the medication can be made.  Nurses at the bedside play a 
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EBP Change Theory  
 There is minimal information regarding EBP and the nurse’s role in deprescribing with 
the utilization of an online tool such as MedStopper®.  It was necessary to pair Rogers’ theory 
with an EBP theory to the needs of the project.  The Stetler Model of EBP (McEwen & Wills, 
2019) was chosen for this project.  The Stetler Model was initially designed in the 1970s as a 
quality improvement model and has been revised several times to make it more useful for the 
nurse at the bedside.  The current model is similar to the nursing process, and the phases are 
incredibly similar to Rogers’ theory steps and thus work together exceptionally well.  The 
“phases of the approach include preparation, validation, evaluation/decision-making, application, 
and evaluation” (McEwen & Wills, 2019, p.112).  The Stetler Model utilizes five phases that 
take into account the clinical situation before using research in the clinical practice at the bedside 
(McEwen & Wills, 2019).  The optimal outcomes should be better patient outcomes and 
improved nursing practice. 
Application to practice change.  Each phase was discussed to explain what actions 
would be taken during that phase of the project.  Phase one; the preparation phase requires a 
definition of the issue and a review of the evidence.  This phase correlated with the literature 
search regarding polypharmacy as a concept and the research available.  It is during this phase 
that a team is developed, and barriers are identified.  Desirable outcomes are determined, and 
investigation is made on the influential factors that can be leveraged (McEwen & Wills, 2019).  
Phase two is the validation of the findings (McEwen & Wills, 2019).  The literature 
matrix was used to critique and culminate resources.  Levels of evidence were used to determine 
the best evidence; however, expert opinions were not excluded.  Non-credible or sources not 
found to be appropriate were eliminated if they did not fit the focus population.  During this 
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phase, a project may be ended if there is not enough evidence or research to proceed.  This 
project topic did indicate sufficient research, as evidenced by the works of Jokanovic, Tan, 
Dooley, Kirkpatrick, and Bell’s (2015) systematic review of the prevalence and factors 
associated with polypharmacy in long term care (LTC) facilities.  This review supported the 
identification of polypharmacy as a serious issue.  The Swedish longitudinal cohort study by 
Morin et al. (2017) supported the need for prescribers to consider discontinuing drugs by 
considering the patient’s life expectancy, the risk of harm, and the patient’s goals of care. 
Phase three is the decision-making phase in which the findings are synthesized, and the 
decision is made whether to continue and what to use to accomplish the desired outcomes 
(McEwen & Wills, 2019). When the decision was made to proceed, the recommendations and 
outcomes were developed, and specific education was planned.  During this time, the 
MedStopper® tool education was also planned, and the tool tested. 
During phase four, the application phase (McEwen & Wills, 2019), the education 
program regarding polypharmacy and MedStopper® was implemented at the LTC facility with 
all nurses with medication administration duties, the hospice nurses involved in the care of the 
patients, as well as all nursing administration.  A weekly chart review was conducted to monitor 
the hospice staff nurse compliance with utilizing the MedStopper® tools plan to collaborate with 
the LTC nurse for medication care planning purposes. The planned outcome was that practice 
would change after the education and nurses would be more invested in reviewing medications 
for discontinuation and make recommendations to the prescribing practitioner and that 
MedStopper® would be incorporated into their regular workflow.  As needed during the 
education programs, education was adjusted to meet the needs of the participating staff. 
REDUCING MEDICATION USE 40 
   
 
Phase five is the evaluation step during which outcome evaluation was conducted 
(McEwen & Wills, 2019) through medication record review to determine improvement as 
evidenced by a decrease in medications in the following drug classes: statins, anti-hypertensives, 
anticoagulants, anti-hyperglycemic agents, and antimicrobials.   A cost savings evaluation was 
also conducted to evidence the savings potential for this program.  A comparison of pre-
education and post-education chart reviews was conducted to assess for a decrease in the number 
of medications in the identified drug classes and the decrease in costs.   
Summary 
 Education was necessary to increase the nurse’s knowledge of polypharmacy and 
strategies to address the safety issues associated with polypharmacy.  Education was also 
necessary to empower the nurses to make deprescribing recommendations to the prescribing 
provider as well as the patient and family.  Education was a key factor in teaching the nurses the 
value of the MedStopper® tool.  By following Rogers’ (1983) Theory of Planned Change, the 
nurses were provided new knowledge about the concept, which created interest in the issue.  
Through education based on research, the nurses were then persuaded that deprescribing was 
beneficial to the patients, the nursing staff, and the organization.  After the education, the 
decision was made to pursue the project and implementation of the MedStopper® tool was 
initiated, the nurses were empowered to have discussions with patients and families and made 
recommendations to the prescribing practitioners. 
 Due to Rogers’ theory and the Stetler Model being so similar to the nursing process, this 
provided a natural way to support the new knowledge and application of the new process.  The 
Stetler Model was well suited to clinical application and easy to follow.  Having determined the 
theoretical foundation and a well-suited EBP change model, the next stage of the project was to 
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develop a pre-implementation plan of how the project was to progress from initiation to 
evaluation.   
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Chapter Four:  Pre-implementation Planning 
Medications are perhaps the most useful tool in modern medicine; however, they are not 
without risks.  This chapter explores how the project was planned and developed.  This chapter 
also discusses the organizations - readiness for change and the collaboration anticipated for 
success.  Risk management is explored through a review of the risk analysis. Finally, a 
discussion of the outcome measurements, evaluation tools, plans for data analysis and data 
management are discussed.   The evidence-based project was planned to educate staff regarding 
polypharmacy, utilization of the MedStopper® tool, and empower nursing staff to recommend 
deprescribing to the patient’s provider.   
Project Purpose  
 The purpose of this proposed evidence-based practice (EBP) change project was to 
recognize and recommend medication reduction in hospice patients residing in long-term care 
(LTC).  To accomplish this purpose, it was necessary to educate all nursing staff responsible for 
medication administration or monitoring.  This included educating nurses in the hospice program 
as well as nurses in the long-term care facility.  The project included the use of the MedStopper® 
online program to help nursing staff identify medications appropriate for deprescribing.  A 2017 
study of 2,623 adults in hospice care indicated that each patient took an average of 10.2 
medications every day (Stinson, Gurevitz, & Carrigan, 2019).  The anticipated outcome of the 
project was to demonstrate an overall decrease in medication use in at least one of the targeted 
drug classes.  Success was dependent on the nursing staff’s ability and willingness to recommend 
medications for deprescribing to the provider. Interprofessional teamwork was necessary if the 
project was to demonstrate a positive outcome.   
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Project Management 
 Prior to the implementation of the EBP change project, organizational readiness was 
assessed to understand the project setting.  The area involved in the project was one of the 
hospice’s contracted LTC facilities.  The LTC facility averages caring for approximately 15-17 
hospice patients per day.  The hospice organization had two nurses that served as case managers 
for the hospice patients residing in the LTC facility.  It was recognized by the hospice nurses that 
LTC patients had a trend toward higher than average medications versus home care patients.  
This observation was confirmed by the hospice’s pharmacy vendor.  It was identified that the 
LTC was a level of care in which the hospice had no direct prescribing authority, and thus was 
an area for improvement.   
Organizational readiness for change.  For change to occur, both the hospice and the 
LTC facility must demonstrate readiness for change.  In discussing the issue of polypharmacy in 
the hospice patient, it was clear that no one organization could effect change without the other.  
According to Rogers’ Theory of Change, it was necessary that both organizations acknowledge a 
need for change (Rogers, 1983).  The hospice was the primary proponent of the project as it was 
the hospice that recognized the issue of polypharmacy and the associated risk to patients, burden 
to LTC staff and financial strain on the hospice budget.   This was brought to the attention of the 
LTC administrator by the primary project manager who provided the administrator with 
benchmarking information.  Information shared included data related to the number of 
medications prescribed to patients per patient day being higher for this hospice as compared to 
other hospices served by the hospice pharmacy vendor.  This information persuaded the LTC 
administrator that this project would be beneficial to the LTC organization.  If successful, this 
project had the potential to increase the quality of the patient’s lives, reduce possible adverse 
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drug events, decrease time and costs associated with staff medication administration time, and 
provide education and tools that would elevate staff’s ability to recognize and address 
polypharmacy in patients outside the hospice scope.  In conclusion, there was a sense of 
organizational readiness by both the hospice and the LTC organization to support the project.   
Inter-professional collaboration. Assembling an operational team that was well 
respected and engaged in patient care was the first necessary step in implementing the EBP 
project.  Leaders, whether formal or informal, influence the actions of others.  The operational 
team consisted of a leadership champion and a practice champion. The hospice Vice President of 
Professional Development, with more than 30 years of hospice experience, served as both the 
primary practice champion and the primary project manager. The role of the primary project 
manager was to educate the hospice and LTC staff, provide and review the printout of the 
MedStopper® tool for each patient to the hospice staff nurse, monitor the patient record for 
MedStopper® tool compliance in using the tool to collaborate with the LTC nurses, conduct data 
collection, conduct remedial education as needed and make adjustments for change strategies as 
needed as indicated through the Plan, Do, Study, Act (PDSA) model (see Appendix B).  The 
LTC Administrator served as the LTC project practice and leadership champion. The role of the 
LTC administrator was to foster the education, provide mentorship to the staff, and assign 
leaders to monitor staff for compliance during routine care planning meetings.  The hospice 
leadership champion was the hospice Chief Executive Officer who provided mentorship to the 
primary project manager.     
The rest of the project team includes the hospice nurse case managers whose 
responsibility was to facilitate discussions of polypharmacy and deprescribing utilizing the 
MedStopper® report with the LTC nursing staff, facilitate discussions regarding deprescribing 
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with the provider, and, if necessary, the patient and family, and model deprescribing discussions 
as needed.  LTC providers were educated on polypharmacy and deprescribing by the hospice 
team’s nurse practitioner.  
Risk management assessment.  An assessment of the change projects’ strengths, 
weaknesses, opportunities, and threats (SWOT) was conducted to identify areas of concern, 
potential threats, and weaknesses. The SWOT analysis was developed to identify the internal and 
external factors that may have an impact on the success of the project.  This analysis helped to 
uncover previously unexpected factors that could be capitalized on or addressed as deficits or 
both.  
Strength. One of the identified strengths was the excellent, long-term relationship 
between the hospice and the LTC facility. Another strength was the resource support of the 
hospice pharmacy vendor, who was able to provide reports to the hospice.  A third strength was 
the primary project manager who had extensive hospice experience.   
Weakness. The potential perception of additional work for staff nurses was identified as 
an inherent project weakness. Another weakness was the time required to provide education to 
all hospice and LTC facility nursing staff that were involved in the administration or monitoring 
of patient’s medications, which included staff on nights and weekends.  An additional weakness 
identified was a lack of standardized scripts and written materials for use when explaining the 
rationale for deprescribing to providers.   
Opportunities. Opportunities that were evident for this change project included the 
collaborative support from the hospice staff working with the LTC facility staff.  Additionally, 
there was the support of the LTC leadership, consulting pharmacist, and staff development 
coordinator to encourage staff participation in the project.  The ability to have the LTC facility 
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host education sessions at flexible dates and times was another important opportunity.  
Tremendous LTC administrator support was an opportunity that fostered a successful 
collaboration on this project.   
Threats. Potential threats identified included limited LTC staff attendance at the 
education sessions and a lack of buy-in. There was an anticipated lack of support from the LTC 
facility providers accepting deprescribing recommendations from nurses.  Another potential 
threat was a lack of understanding the benefits for patients, such as reduced adverse drug events, 
decreased hospitalizations and increased quality of life.  For staff, medication administration 
burden and time spent assessing for and treating adverse drug events is time-consuming but any 
additional focus on medications could have been negative.   
For the organization as a whole, the benefits include cost savings by reduced adverse 
drug events, reduced cost in medication administration leaving more time for staff to provide 
enhanced patient care, and a decrease in re-hospitalizations.  However, it was crucial to use 
education to overcome the threat associated with the understanding of these potential positive 
outcomes.   
Organizational approval process.  Organizational approval was obtained after 
presenting the hospice pharmacy reports indicating the hospice exceeded the national average for 
medications per patient for hospice patients residing in LTC facilities.  The hospice chief 
executive officer provided a letter of approval for the project and agreed to serve as the hospice 
site project champion (see Appendix C).  The primary project manager met with the facility 
administrator and explained the project plan and expected outcomes.  Explanations were made 
that the data, chart reviews, and pharmacy data would all come directly from the hospice medical 
record and there would be no data mining from the LTC record.  It was explained that in order 
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for the project to be successful, it was necessary to teach both the hospice nursing staff and the 
LTC facility staff to identify polypharmacy and recommend deprescribing to the providers.   It 
was explained that the primary project manager would collect a pre- and post-education survey 
tool at the time of the facility education sessions. Organizational approval was obtained from the 
LTC facility’s ownership for the education of staff on MedStopper® (see Appendix D). 
Information technology.  The online internet-based tool MedStopper® was printed for 
each hospice patient residing in the LTC facility at the time of project implementation, for each 
LTC patient admitted to the hospice during the project duration and updated for each patient 
every week as new medications were added or stopped.  The primary project manager printed the 
MedStopper® report for medications within the target drug classes within two working days and 
reviewed the report with the hospice nurse, who then reviewed the report with the LTC nurse.  
An Excel data collection tool was utilized to assess data from weekly hospice chart reviews for 
each hospice patient to monitor the targeted drug classes to compare and contrast for 
deprescribing.  Patients were not identified in the Excel data collection tool and were assigned a 
non-identifiable number to manage data analysis.   
Education for hospice and LTC nursing staff was presented using a PowerPoint 
presentation.  Staff were provided handouts of the slides and time was allotted for questions 
during the education session.  The primary project manager provided available contact 
information to the hospice and LTC staff for any further questions.   
Cost Analysis of Materials Needed for Project 
Minimal materials were needed for the change project.  The project materials included: 
approximately 500 sheets of 8 ½ x 11 copy paper for educational handouts and flyers at an 
estimated cost of $45.00.  The hospice organization and hospice pharmacy vendor provided 
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computer support for monitoring the data.  The MedStopper® program is available online at no 
cost.  Snack food was provided for training of the hospice nursing staff as well as the LTC 
facility nursing staff at an additional cost of approximately $50.00.  The total estimated cost for 
the project was $95.00 (see Appendix E). 
This project had the opportunity to save the LTC facility in a reduction in staff 
medication administration time.  It is estimated that for each oral medication added to a patient’s 
oral medication pass it takes an additional 45 seconds; thus, the cost of adding that drug can be 
between $7 and $21/day per patient; even if the medications are passed at the same time 
(Pruskowski, Zarowitz, & Handler, 2018).  Therefore, assuming the project would lead to the 
deprescribing of at least one drug per patient, administered one-time daily times the average 
hospice caseload of 15 patients the savings for the LTC facility is estimated at daily cost savings 
of $105.00 at a minimum and $315.00 at maximum.   The savings for the hospice program was 
more difficult to predict as the cost of the drug deprescribed varied widely and could not be 
easily foreseen prior to implementation. Given these cost-saving projections, the project benefit 
outweighed the project cost.   
Plans for Institutional Review Board Approval 
The Institutional Review Board (IRB) is a committee responsible for reviewing research 
to confirm that the investigator is conducting ethical research (Grove, Burns, & Gray, 2015). 
Planning for the IRB review process began with meeting with the LTC project champion to 
discuss the project and the steps for IRB review through the LTC organizational IRB as the 
hospice organization did not have an IRB committee.  The first step of the IRB process was to 
complete the University QI/Program Evaluation Self-Certification Tool specific to the project for 
review by faculty lead.  
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The LTC project site’s office that oversees research was consulted by phone for IRB 
quality improvement project review.  A project proposal was emailed to the director on October 
10, 2019, and a quality improvement project summary guide was submitted to the LTC 
organization’s IRB office and deemed to be a quality improvement project and granted a waiver 
of approval.  The LTC project site IRB waiver of approval was obtained and forwarded to the 
primary project manager on November 15, 2019 (see Appendix F).  The University QI/Program 
Evaluation Self-Certification Tool for IRB review process was completed, and an approval 
waiver was provided by the University and obtained on November 15, 2019 (see Appendix G).    
Plan for Project Evaluation 
Demographics.  Demographics collected included roles of the nursing staff involved in 
the education sessions as well as years of experience working in the LTC setting.  Data was 
collected on the pre and post-education survey. Roles and years of experience were presented as 
a mean score and range noted in table format.  The purpose of demographics was to gather 
information to be used during the PDSA cycles to identify any additional educational needs.   
Outcome measurement: Nursing knowledge.  Nursing staff knowledge was chosen as 
an area of focus.  Improving the knowledge of nursing staff in the effects of polypharmacy is 
vital to the confidence of staff to recommend the deprescribing of medications to the provider.  
Nursing staff administering medications are in key positions to advocate for identifying the 
effects and side effects of medications and make recommendations to providers.    
Evaluation: Nursing knowledge. Nurses educated were asked to evaluate the education 
and knowledge perception using a Pre-Education Program Evaluation tool and a Post-education 
Program Evaluation tool (see Appendices I & J). The Pre-Education tool evaluation measured 
the nursing staffs’ responses regarding the staffs’ level of comfort using the following format: 
REDUCING MEDICATION USE 50 
   
 
very uncomfortable, uncomfortable, comfortable, and very comfortable with identifying 
polypharmacy and suggesting deprescribing to the provider (see Appendix I).    
The Post-Education tool evaluation measured the nursing staffs’ responses regarding the 
staffs’ level of comfort using the following format: very uncomfortable, uncomfortable, 
comfortable, and very comfortable with identifying polypharmacy and suggesting deprescribing 
to the provider after education. The post-education tool also included a question related to 
nursing staffs’ response regarding the likeliness to use the information provided during the 
training.   Participants were also asked to indicate specifically what the participant intended to 
use in their daily practice, what he/she wished had been learned during the education 
presentation and the primary motivation for attending.  These three questions were captured in a 
narrative format (see Appendix J). 
Data analysis: Nursing knowledge.  The pre-education survey data was collected via the 
Pre-Education Nursing Staff Survey tool in January 2020 prior to each educational session.  The 
average scores for each question were recorded in table format using frequencies.  The post-
education survey data were collected via the Post-Education Nursing Staff Survey tool in 
January 2020 after each educational session.  Answers for each question were then documented 
in table format displaying the frequency of each answer.  A comparison of the aggregate pre- and 
post-education survey results was reviewed and presented through a table format as well as a 
chart and summative narrative including percentages (See Appendix K).  These results were 
utilized as a part of the PDSA cycle to focus on additional educational needs for the participants.  
The final results of the project were displayed in a poster format for presentation at the hospice 
and LTC facility.  
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Outcome measurement: MedStopper® compliance. The MedStopper® tool is an 
online tool designed to assist the professional caregiver to identify and prioritize medications for 
deprescribing (see Appendix K). This medical tool incorporates other deprescribing resources 
such as Beers and STOPP criteria as well as the Edmonton Frail Scale.  Permission to utilize the 
MedStopper® tool was obtained for use (see Appendix M).  
The MedStopper tool was printed for each hospice patient residing in the LTC facility at 
the time of project implementation by the primary project manager.  Additionally, the 
MedStopper tool was printed for each new hospice patient admitted during the 12-week 
implementation period and weekly for all hospice patients in conjunction with weekly 
medication order reviews.  The MedStopper tool’s printed plan was given to the hospice nurse 
responsible for the hospice care of the patient, and the plan was reviewed.  The hospice nurse 
then utilized the plan to facilitate a medication plan discussion with the LTC facility nurse.  This 
discussion provided an opportunity for the staff to discuss potential deprescribing 
recommendations for the provider to consider.  This collaboration was documented by the 
hospice nurse in the clinical notes of the hospice electronic medical record.  A process map was 
designed to outline the process for the utilization of the MedStopper® tool and report (see 
Appendix N). 
          Evaluation:  MedStopper® compliance. The primary project manager created a 
MedStopper® Compliance Tool Excel spreadsheet for weekly use (see Appendix O).  A chart 
review was conducted weekly, by the project manager, to evaluate hospice nurse utilization of 
the MedStopper® tool.  Monitoring the MedStopper® tool utilization assisted in the evaluation 
of staff compliance and identify opportunities for improvement in the process.  
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Data analysis: MedStopper® compliance. Descriptive statistics using percentages and 
frequencies were utilized to displaying results.  Weekly chart was used to track utilization 
compliance.  A compliance percentage was determined by dividing the number of “Yes” answers 
by the total number of MedStopper® tools, the number was then multiplied by 100 to get a 
percentage of compliance.  A 95% compliance rate was expected by the primary project 
manager.    
Outcome measurement: Polypharmacy reduction.  The expected outcome of the 
education intervention was to see a decrease in at least one drug in at least one of the following 
drug categories: vitamin/supplements, statins, anticoagulants, cognitive enhancing, 
antihypertensives, and antihyperglycemics.  Education of the nursing staff in polypharmacy and 
initiating discussions with providers regarding deprescribing of medications were crucial for the 
actual deprescribing of such medications.  As part of the PDSA review cycle, the number of 
medications being deprescribed in the hospice patient guided further education with hospice and 
LTC facility staff.   
Evaluation:  Decreasing identified medication category utilization. A Data Collection 
Tool was created to track weekly medication usage (see Appendix P).  The tool consists of an 
unidentifiable patient number, the number of drugs prescribed per each drug category. Weekly 
chart review by the primary project manager review was conducted using the hospice medical 
record and hospice pharmacy vendor reports to evaluate patient medication usage. 
Data analysis:  Decreasing identified medication category utilization.  Hospice 
medication records were reviewed weekly and transcribed to the Excel Data Collection Tool to 
evaluate trends in deprescribing.  Weekly review monitoring for a decrease in the medications in 
the targeted drug classes was completed.  Data were evaluated for a goal of a decrease in at least 
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one medication from at least one targeted medication category for each patient.  Overall 
medication utilization was not monitored as it was expected that symptom management 
medications would be added as the condition of the patient declined.  Data were utilized to 
determine if further education in a specific drug category was indicated, as part of the PDSA 
cycle. This data was presented weekly utilizing a table that showed the number of prescribed 
medications in each category to monitor for a decrease.  
Data management.  Paper survey tools were collected before and after each education 
session. No identifying information was included in the pre and post-survey tools.  The pre and 
post-survey results were aggregated into an Excel table format and stored in a password-
protected computer file located on the personal computer in the home office of the primary 
project manager.  Copies of the survey tools were transported in a locked briefcase and 
subsequently stored in a locked file drawer located in the home office of the primary project 
manager.   
Patients were not identified in the Excel data collection tool but were assigned a non-
identifiable number to manage data analysis.  Data was collected on an Excel data collection tool 
and stored on a password-protected computer in the private home office of the primary project 
manager.  The primary project manager utilized a code sheet that tracked the patient’s hospice 
medical record number and non-identifiable number for ongoing data collection and monitoring.  
The code sheet was stored in the locked office of the primary project manager. The completed 
MedStopper® Compliance Tool was kept on a password-protected computer in the private home 
office of the primary project manager.  The home office of the primary project manager is 
accessible only by the primary project manager.  Only aggregate findings were presented in 
PowerPoint presentation to the hospice and LTC facility.  All survey tools, hard copy data files, 
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and digital files will be kept for five years after the conclusion of the project.  All digital files 
will be deleted, and hard copies of all survey tools will be shredded.  
Summary 
 The education of nursing staff and collaboration between the hospice nursing staff and 
the LTC nursing staff was vital to providing a base for identifying and recommending 
medications for deprescribing in the hospice patient.  Simple, easy to use tools are key to 
ensuring understanding and fostering discussions.  There is sufficient literature to support the 
theory that nurses are key to the identification of polypharmacy and thus have a vital role in 
collaborating with the provider to ensure safe and effective medication management.  Tools such 
as MedStopper® can be used to foster an awareness of the importance of good medication 
stewardship.  This training was used to expand the nurses’ knowledge and foster confidence in 
recommending medications for deprescribing.   
 The planning phase of any change project is crucial to the project’s success.  Learning 
and understanding the needs of both the hospice and the LTC organization, learning and 
understanding the requirements of each organization’s IRB process, discovering the strengths 
and weaknesses of each organization, a plan for success was then possible.  The next step of this 
change project was to begin the implementation phase.   
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Chapter Five: Implementation Process 
Implementation is the step in any quality improvement project in which planned 
interventions are put into action and evaluated.  This chapter explains the setting where the 
interventions took place, staff participating in the project, how the participants were recruited, 
and each step of the implementation process.  Variations in the plan were made as a result of the 
weekly review as a part of the Plan, Do, Study, Act (PDSA) model. These variations are 
discussed in this chapter.   
Setting 
 There were two settings for this 12-week quality improvement project. First was a rural, 
free-standing, non-profit hospice with an average daily census of approximately 160 patients per 
day.  Of those 160 patients, approximately 10% of those patients reside in long-term care (LTC) 
facilities and are primarily cared for by the staff of the LTC facility with the hospice staff 
visiting twice weekly to provide hospice and palliative oversight.   The second was the LTC 
facility located in the service area of the hospice.  This LTC facility is owned and operated by a 
major, well-established southeast healthcare system located in central North Carolina (NC) and 
is a crucial part of the local hospital’s discharge planning.  Both the hospice and the LTC facility 
are in a rural county with a July 1, 2018 census of 97,645.  Of the county’s population, 18.69% is 
over the age of 65 years (United States Census Bureau, 2019).   
Participants 
The participants of this project are LTC and hospice nurses caring for the hospice patients 
residing in the specified LTC facility. The Centers for Medicare and Medicaid Services (CMS) 
specifies in Hospice Regulation §418.112 that the hospice staff and the LTC staff must 
collaborate to provide care for the hospice patient residing in the nursing home.  This project was 
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designed to provide education and a deprescribing tool that would be used by both the hospice 
and LTC nurses caring for the individual hospice patient.  CMS holds the hospice responsible for 
the professional management of the care plan of these patients. Thus, the hospice needed to take 
responsibility for developing medication recommendations for deprescribing (U.S. CMS, 2019).  
Participants included the hospice nurses and the LTC nurses responsible for administering 
medications or supervising those nurses.  
Recruitment 
 The nurses at both the hospice and the LTC facility were required to attend one of the 
education sessions provided by the primary project manager.  The education sessions were 
scheduled on multiple dates and times for attendance to be convenient for those participants.  
Flyers were posted at the nursing stations of the LTC facility as well as the clinical area at the 
hospice facility to inform participants of the upcoming training and generate interest in the topic 
(see Appendix H).  The primary project manager was available to provide individual training for 
any staff not able to attend previously scheduled education sessions as well as to those staff 
members that had specific questions not answered by the mandatory education sessions.   
Implementation Process 
 The project was implemented by the primary project manager in January 2020.  An initial 
chart review of all of the medication records for hospice patients at the LTC facility was 
conducted the week before implementation to gather baseline information. Education included an 
overview of the project, a review of the MedStopper® tool, a review of the process map, and 
strategies for recommending deprescribing to providers.  Before each education session, a survey 
was given to all participants to evaluate the comfort level in identifying polypharmacy and 
recommending deprescribing to providers. Education was provided to the participants over one 
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week at the LTC facility that included the LTC nurses as well as the hospice nurses. Following 
the education, a second survey was distributed to all participants to evaluate the comfort level in 
identifying polypharmacy and recommending deprescribing to providers after education.  The 
post-education survey also evaluated the participant’s likelihood to use the education provided 
and asked what specifically was learned and what more the participant wished had been 
provided.    The pre- and post-education surveys were placed in a box at the entrance of the 
room, collected by a member of the LTC staff, and given to the primary project manager at the 
end of each education session.   
MedStopper® reports were printed and provided to the hospice nurses in the first week of 
implementation for all active patients in the LTC facility. The hospice electronic medical record 
(EMR) was reviewed weekly by the primary project manager to monitor for new patients, for 
patients that had been discharged, and for any newly prescribed or deprescribed medications for 
those patients in the project.  Compliance was documented in the MedStopper® compliance tool 
(see Appendix N).  Each week over 12 weeks, the EMR was reviewed by the primary project 
manager to evaluate compliance with the hospice nurse using the MedStopper® report to 
collaborate with the LTC facility nurses.  Weekly reviews of the Targeted Drug Classification 
tool were conducted to evaluate a reduction in medication usage (see Appendix O).  
Plan Variation  
The project manager planned to make on-site reviews of medications throughout the 
project implementation.  Through the Plan, Do, Study, Act (PDSA) model, the project manager 
learned that it was necessary to utilize some way to keep the LTC employees engaged in the 
project.  This realization led to the development of a one-page tool, including the outcome 
graphs, short narratives supporting deprescribing, and photos of staff with the project mascots, 
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two pink stuffed elephants LTC staff named “Polly” and “Macy”.  The mascots were placed in 
prominent areas of each nursing station with the intent to inject a sense of anticipation and fun 
into the participation in the project.     
A worldwide COVID-19 pandemic made it impossible to enter the LTC at the end of the 
implementation period.  As a result, the project manager used WebEx and Zoom virtual meeting 
platforms to review medication lists with the hospice nurse, the LTC pharmacist, and the hospice 
nurse practitioner (NP) on two occasions.  The project manager was able to continue the use of 
the one-page LTC updates.  These one-page updates were provided to the hospice nurse who was 
able to place these at the nursing stations, the LTC physician/NP office, and the LTC 
administrator’s office every other week. While these changes were necessary, they may have 
impacted the LTC staff’s ability to feel fully integrated into the project.    
Summary 
 Implementation of this evidence-based project involved the project manager in using 
skills learned throughout the doctoral program.  Skills included gaining knowledge regarding the 
settings for the project, including obtaining the support of the administration of both the hospice 
and the LTC facility.  Also, participants were recruited, and education provided to ensure 
engagement in the project.  Implementation required the use of technology to educate as well as 
share period outcomes to facilitate on-going commitment.  The PDSA process was used, leading 
to slight variations to increase engagement. As a corona virus pandemic forced the abandonment 
of personal interventions, the project varied again to engage staff via other means such as 
computerized meetings and the use of the hospice nurse to deliver updates to staff.     
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Chapter Six:  Evaluation of the Practice Change Initiative 
After the implementation of the Doctor in Nursing Practice (DNP) project, evaluation of 
the practice change initiative was conducted. Measures included determining the knowledge of 
the nursing staff before implementation by evaluating the feedback provided by attendees 
through a pre-education and a post-education survey. Additional measures were to determine the 
compliance of the hospice nurse utilization of the MedStopper® tool to collaborate with the 
long-term care (LTC) facility nurses and providers and finally evaluate for a decrease in 
medications prescribed for hospice patients within the identified medication categories. The 
purpose of this chapter is to discuss the evaluative measures in detail. 
Participant Demographics 
 Education sessions were held at the LTC facility to provide information regarding the 
topic of polypharmacy.  Live education was provided to the LTC and hospice nurses responsible 
for managing medications. Training included how to recognize polypharmacy and how to initiate 
discussions with patients and family members.  Training also covered how to communicate with 
providers and how to recommend deprescribing medications.  Twenty-two LTC and hospice 
staff nurses attended the live training with 16 returning the pre- and post-education surveys.  Of 
those that returned surveys, 56% (n=9) identified as licensed practical nurses (LPN), 13% (n=2) 
identified as registered nurses (RN), and 31% (n=5) identified as RN supervisors.  It was 
essential to gather this demographic data to guide one-on-one education during the project 
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Intended Outcomes 
 This project had three defined outcomes.  The first outcome was to measure the education 
of the staff nurses included in the project before and after the education session.  It was expected 
that at least 50% of the LTC staff nurses would attend a live education session, which was 
recorded for remaining staff nurses to view.  The involved nurses needed to understand the 
terms, the intent of the project, and the value that deprescribing had for the patient, facility, and 
nursing staff.  It was also vital the nurses felt empowered to contribute to the project’s success.  
Attendees were asked to complete a survey before the training.  The survey asked nurses to 
identify how comfortable they were in recognizing polypharmacy and recommending 
deprescribing to the provider.  After the education was presented, the nurses were again asked to 
identify how comfortable they were in recognizing polypharmacy and recommending 
deprescribing to the provider.  As a part of the post-education survey, attendees were also asked 
how likely they were to use the information, and specifically what they had learned.  This 
information was then used during rounding at the LTC facility. 
 The second outcome stated that the hospice nurse would be compliant with the utilization 
of the MedStopper® report.  The MedStopper® tool utilizes Beers, STOPP criteria, and the 
Edmonton Frailty scale to identify which medications should be considered for deprescribing. 
This tool’s report provided the hospice nurse and the LTC facility nurse with a guideline for 
initiating deprescribing conversations with patients, family members, and providers.  
Compliance in using MedStopper® report was measured through dialogue with the hospice 
nurse and weekly chart reviews.  For success, the nurses needed this additional education 
specific to each patient and medication regimen.  
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 The third outcome was to evaluate any decrease in medications in the seven identified 
drug categories.  Hospice medical records were reviewed weekly to monitor trends in the 
identified drug categories.  Success was a decrease in at least one drug for each patient in one of 
the drug categories.  Successful deprescribing represents nurses that felt confident and 
comfortable in recommending discontinuing medications to the providers as well as having 
discussions with patients and families.  A decrease in unnecessary medicines has the potential to 
improve patient’s quality of life and decrease the possibility of adverse medication events that 
lead to poor patient outcomes as well as financial strain on the healthcare system. 
Findings  
 Nursing knowledge.   Findings indicate that the educational portion of the project was 
impactful on the individual nurse level.  For data collections, attendees signed an attendance 
sheet upon admission to count the number of attendees. Sixteen attendees completed a pre-
education survey that included questions regarding their role and years of experience in order to 
understand the demographics of the staff.  The evaluation also included questions asking 
attendees to rate comfort recognizing polypharmacy and comfort in suggesting deprescribing to 
the provider.  In response to the comfort recognizing polypharmacy, a total of 16 (73%) pre-
education surveys were returned.  Nine (56%) out of 16 stated they were comfortable with 
recognizing polypharmacy with five (31%) out of 16 stating they were very comfortable with 
recognizing polypharmacy.  Attendees then rated comfort suggesting deprescribing to the 
provider with 56% (n=9) stating they were comfortable recognizing polypharmacy and 31% 
(n=5) stating they were very comfortable suggesting deprescribing to the provider.  
 Immediately following the education session, attendees were asked to complete a post-
education survey asking comfort recognizing polypharmacy, comfort in suggesting deprescribing 
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to the provider, and the likelihood to use the education provided. Sixteen post-education surveys 
were returned with seven (44%) out of 16 reporting they were now comfortable recognizing 
polypharmacy and nine (56%) out of 16 stating they were now very comfortable suggesting 
deprescribing to the provider.  The attendees also rated their likeliness to use the education 
provided, and 13 (81%) out of 16 indicated they were very likely to use the education. The post-
education survey included a question asking the attendee to write what they were likely to use.  
The responses fell into two main categories, with eight (62%) out of 13 indicating they would 
use a better understanding of medications and five (38%) out of 13 indicating they better 
understood how to communicate with the provider, the patient/ family, or the hospice nurse.   
Table 1 
 Pre- and Post- Education Survey Results  
    Pre-Education Post-Education 
Comfortable recognizing polypharmacy Very uncomfortable 1 0 
  Uncomfortable 1 0 
  Comfortable 9 7 
  Very Comfortable 5 9 
  no answer 0 0 
Comfort suggesting deprescribing Very uncomfortable 0 0 
  Uncomfortable 2 0 
  Comfortable 9 9 
  Very Comfortable 5 7 
  no answer 0 0 
Likelihood to use education Very unlikely n/a 0 
  Unlikely n/a 0 
  Likely n/a 3 
  Very likely n/a 13 
  no answer n/a 0 
 
Note. A total of 22 staff attended education with 16 participants returning a survey.   
 MedStopper® utilization. The utilization of the MedStopper® report was measured 
weekly through chart review and conversations with the hospice nurse.  Utilization was defined 
as taking the MedStopper® report to the LTC facility, reviewing the report with the staff, and 
REDUCING MEDICATION USE 63 
   
 
placing the report on the hard copy LTC facility chart.  In the 12 weeks of review, 132 of 145 
(91%) reports were utilized by the hospice nurse.  A 95% compliance rate was expected; 
however, the primary hospice nurse was on vacation for a total of six days and the nurse seeing 
the LTC patients did not utilize the MedStopper® tool during the visits.  The hospice nurse, the 
hospice nurse practitioner, and the project manager felt that providing a tool to the LTC staff 
provided needed evidenced-based education that would be useful in improving communication 
with the patient, patient’s family, and providers about the possibility of deprescribing.   
 Polypharmacy Reduction: Hospice medical records were reviewed initially before the 
education and implementation of the MedStopper® tool and subsequently for 12 weeks to 
evaluate trends in deprescribing for the seven identified drug categories, vitamin/supplements, 
gastrointestinal (GI) reflux, statins, anticoagulants, cognitive enhancing, antihypertensives, and 
antihyperglycemics.  The goal of the project was to see a reduction in at least one drug in at least 
one drug category for each patient.  Initially, there were 13 patients reviewed. Medication 
reviews were conducted each week on Saturday or Sunday, measuring the total numbers of drugs 
in the targeted drug categories and developing an average of medications in each drug category 
by dividing the number of drugs by the total number of patients.  Of the 13 initial patients at the 
LTC facility, there were a total of 32 drugs in the targeted categories, which was an average of 
2.46 targeted medications per patient.    The project had a total of 18 patients through the 12-
week period with 6 patients dying, 2 patients transferring out of the LTC, and 1 patient revoking 
out of the hospice program leaving only 10 patients in the project at its conclusion.  At the 
conclusion of the project there was a decrease in total targeted medications from 2.6 to an 
average of 1.3 per patient (See Appendix P).  
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 In reviewing each drug category, all medications resulted in an overall decrease by the 
end of the project.  There were fluctuations throughout the 12 weeks as medications were 
deprescribed, and new patients entered the project, and patients dropped out of the project by 
death or discharge.  Drugs ordered for GI reflux reflected the most decrease with significant 
decreases noted in the use of vitamin supplements and antihypertensive drugs. Of note, there 
were very few patients on statins or cholesterol-lowering medications and no patients throughout 
the project on cognitive-enhancing medications (see Appendix Q).   
 
Figure 2. Targeted medication category throughout the data collection period.    
Vitamin supplements. Vitamins increased in weeks 5 and 6 significantly.  This increase was 
noted to be due to two patients admitted into the project.  By week 7, the first patient’s 
medication profile was reviewed, and the patient’s three vitamin supplements were deprescribed.  
























Data Collection for Targeted Drug Categories
Vitamin Supplements GI Reflux Statins/ Cholesterol lowering
Anti  coagulants Cognitive enhancing Anti hypertensives
Diabetics
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 Gastrointestinal (GI) reflux. It was noted that the majority of the patients in the project 
were taking a GI medication.  In data analysis, 8 (62%) of the initial 13 patients were taking GI 
medications. Three of the next four patients admitted into the project were taking a GI drug, and 
of those patients, all but one was able to have their GI drug deprescribed before the end of the 
project. 
 Statins/ cholesterol-lowering. Unexpectedly, only one patient in the project was taking 
medication to lower their cholesterol.  A new patient admitted to the project in week10 was 
admitted on a statin.  This medication was deprescribed within a week of admission into the 
project. In the project participants, cholesterol-lowering drugs were not the issue anticipated.    
 Anticoagulants. Initially, 4 (31%) of 13 patients were taking an anticoagulant.  In 
analyzing the diagnoses of the patients, most of these patients had a diagnosis of atrial fibrillation 
as a secondary diagnosis.  It was not possible to determine how long each patient had been on 
this medication due to access only to the hospice medical records.  Two additional patients 
admitted into the project were also prescribed an anticoagulant.  Only two (33%) of the six 
patients were able to have the anticoagulants deprescribed.   
 Cognitive enhancing. It was a very unexpected finding that none of the patients involved 
in the project were on a cognitive enhancing medication, despite the fact that many patients had a 
dementia diagnosis listed as a secondary diagnosis.  Chart reviews did not give insights of 
whether the patients had failed these medications or if these medications had been previously 
prescribed.  It was anticipated during the planning that this medication would be a problematic 
medication for family members and providers to agree to deprescribing.   
 Antihypertensive.  Seven (54%) of the initial 13 patients in the project were taking 
medications intended to lower blood pressure.  Within the first week of the project, two patients 
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were able to have their antihypertensive deprescribed.  Two of the subsequent four patients 
admitted into the project were taking blood pressure-lowering drugs.  Of note, one patient 
admitted into the project in week six was taking three antihypertensives.  This particular patient 
even required the addition of a 4th medication during week ten, but the total number was reduced 
back to 3 during week 11.  A chart review of this patient revealed a primary cardiac diagnosis 
and hypertension as a significant issue, thus, and it was not medically appropriate to recommend 
deprescribing this medication for this patient.   
 Diabetics. In the initial 13 patients, only one patient was prescribed a diabetic 
medication.  In week two, a new patient admitted into the project was taking three different 
antidiabetic medications.  In week 6, it was possible to deprescribe one of the medicines, but the 
patient indicated a need to remain on two medications for optimal control of their blood sugar.  
Chart review of this patient indicated that control remained stable with only two medications.  In 
week 8, another patient was admitted into the project with two diabetic medications; however, 
that patient died within a few days, and no deprescribing was recommended.   
Summary 
 Overall, there were 18 patients admitted to the project in the 13 weeks.  Initially, 13 
patients were in the project with six patients admitted into the project as they were admitted into 
the hospice program.  During the 13 weeks, nine patients were discharged out of the project by 
death or transfer out of the LTC facility.   
 The LTC and hospice nursing staff reported increased comfort in recognizing 
polypharmacy after the education session.  The nurses also reported a higher comfort level in 
suggesting deprescribing to the providers after the education.  Over 80% also reported they were 
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very likely to use the education provided indicating that increasing knowledge was a positive 
step toward decreasing unnecessary medications.   
 The MedStopper® tool’s printed plan was printed weekly and reviewed by the hospice 
nurse responsible for the hospice care of the patient.  The hospice nurse then utilized the plan to 
facilitate a medication plan discussion with the LTC facility nurse.  This discussion provided an 
opportunity for the staff to discuss potential deprescribing recommendations for the provider to 
consider. The plan was placed in the patient’s medical chart for review by the LTC team to 
support the deprescribing of medications. 
 The data analysis showed a decrease in the medications in the targeted drug categories.  
Each drug category, despite increases when patients were admitted into the program, showed an 
overall decrease by the end of the project.  This deprescribing trend demonstrated that the 
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Chapter Seven:  Implications for Nursing Practice 
The American Association of Colleges of Nursing (AACN, 2006) established the eight 
Doctor of Nursing Practice (DNP) essentials to serve as “the foundational outcome competencies 
deemed essential for all graduates of a DNP program regardless of specialty or functional focus” 
(p. 8).  These essentials were used to guide the project’s steps and ensure the project was 
approved by leadership, was evidence-based, advanced nursing practice, and shared as 
appropriate with all stakeholders. This chapter outlines how this DNP project met the AACN 
essentials.   
Practice Implications   
Essential I:  Scientific underpinnings for practice.  Essential I serves to take the 
knowledge gained in nursing science to the highest level of nursing practice (AACN, 2006).  The 
doctor of nursing practice (DNP) prepared nurse is responsible for integrating nursing science as 
well as science from other disciplines such as medicine, pharmacy, and ethics into their practice.  
DNP nurses are also expected to use existing knowledge and theories to generate new nursing 
knowledge that leads to improved practices.   
A literature review was completed to determine the background and clinical significance 
of polypharmacy in the patient residing in the long-term care facility.  Based on the literature 
review, a quality improvement project was implemented to translate the research to practice at 
the hospice and long-term care clinical sites. The literature indicated that polypharmacy was 
indeed a problem for many patients residing in the long-term care setting and had the potential to 
lead to adverse drug events, increased costs, and a decreased quality of life for the patient.     
Everett Rogers’ Theory of Planned Change served as the theoretical framework for this 
project and the concepts were reviewed as part of the literature review.  The Plan, Do, Study, Act 
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(PDSA) model served as the evidence-based quality improvement model to implement the 
project and assess for changes required throughout the project.  The nurses at both the hospice 
and the long-term care facility (LTF) site needed the project manager to plan a model based on 
the literature available and then develop interventions that were then reviewed and updated as 
needed.  A future recommendation is for organizations and DNP leaders to be grounded in a 
strong theoretical framework to provide the structure needed to critically think through an 
evidenced-based project to achieve the most positive outcome.   
Essential II:  Organization and systems leadership for quality improvement and 
systems thinking.  Essential II requires the advanced practice nurse to include organizational 
and systems leadership components to foster positive health outcomes and ensure patient safety 
(AACN, 2006).   A future recommendation is that the DNP prepared nurse to commit to 
understanding the stakeholders, the leadership as well as cost issues and then use that knowledge 
to lead the organization to develop and initiate quality improvement projects to improve the 
quality of the care provided to the population of patients being cared for.    
The project was designed to meet the needs of hospice patients residing in long-term care 
(LTC). Key stakeholders at the LTC site, the hospice site were included during the planning 
stages to determine the need, the degree to which participation would be expected and the 
outcomes that would be expected.  A project budget was developed, and education plans were 
made to facilitate the project.  An Institutional Review Board (IRB) waiver and approval for the 
primary clinical site were obtained for the quality improvement project.  Through the PDSA 
model, it was apparent that sharing the outcomes with the staff was important and thus outcomes 
were shared frequently during the project through 1-page newsletters that were posted at the 
nursing stations.   
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Essential III:  Clinical Scholarship and analytical methods for EBP.  Essential III 
focuses on translating new science, collaborative research, and generating evidence through 
clinical practice to guide improvements and outcomes of care (AACN, 2006). The DNP prepared 
nurse must take existing research and new science and determine the outcome that has the most 
potential to affect positive change.  The future implication is for the DNP nurse to use existing 
knowledge and determine organizational practices and protocols that need to be changed and 
then facilitate sustainable change that will benefit the organization, clinical practice, and patient 
outcomes.   
This quality improvement project used recent research, articles, and evidence-based 
guidelines to develop a quality improvement project using both education and the use of an on-
line tool, MedStopper, to assist nurses in making effective, efficient recommendations about 
patient care.  Outcomes were monitored weekly and data was analyzed and shared with 
stakeholders periodically to sustain the change. The outcomes were disseminated to the 
stakeholders, the leaders of both the hospice and the long-term care facility.   
Essential IV:  Information systems/technology and patient care technology for the 
improvement and transformation of healthcare.  Essential four ensures that the DNP prepared 
nurse can utilize technology to initiate quality improvement, support practice, and administrative 
decision-making.  The essential also ensures the student uses technology to monitor and report 
quality improvement outcomes (AACN, 2006).  It is recommended the DNP nurse be 
responsible for knowing how to extract data from the electronic health record and create plans 
based on this data.  The DNP must then use technology to compile data into spreadsheets and 
graphs that can be utilized by organizations to monitor the need for change as well as to share the 
data with stakeholders during and after the completion of a quality improvement project.  
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This project utilized an on-line program, MedStopper, to generate deprescribing 
recommendations. The MedStopper® on-line tool is designed to support the nurses as they made 
recommendations for the deprescribing of medications for the hospice patient in the LTC facility.  
The DNP project manager obtained written permission to utilize the tool from the tool’s creator 
before using the technology.  Education for the nursing staff was provided using PowerPoint 
slides and was recorded via the long-term care facility’s education director’s iPhone for staff 
unable to attend to be able to view.  Technology was also incorporated during the analysis and 
reporting phase through the use of Excel tools and graphing technology. The data was compiled 
weekly using Excel spreadsheets and then graphed through Excel for periodic dissemination to 
the staff nurses at the long-term care facility and the hospice to maintain interest in the project.   
Essential V: Healthcare policy for advocacy in healthcare.  The DNP graduate is 
prepared to assess, analyze and implement policy at the institutional, local, state, regional, 
federal, and international levels while serving as leaders in the practice arena thus serving as a 
bridge between research, policy and resulting practice (AACN, 2006).  A future implication of 
this essential is that the DNP nurse analyzes current policies and develop new policies for all 
nursing levels and must provide professional leadership regarding the implementation of those 
policies in nursing practice.  
This project analyzed and recognized a need to provide front-line nursing staff with an 
evidence-based tool to assist in decision making for medication management in the hospice 
patient. While the unspoken policy was for medical staff to make all decisions, this project 
sought to alter this policy at the institutional level by empowering nurses to use research and 
tools to change practice and ultimately encourage nurses to make deprescribing 
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recommendations that would improve the quality of life for patients, reduce the pharmacy cost 
incurred and reduce the likelihood of patient hard due to adverse drug events.   
Essential VI:  Interprofessional collaboration for improving patient and population 
health outcomes.  DNP prepared graduates are required to be efficient in collaborating with 
interprofessional members of the healthcare team to change policy and practice (AACN, 2006) 
effectively.  It is recommended that the DNP nurse incorporates the multi-disciplinary team to 
develop health policy, the DNP must assume responsibility for facilitating communication 
between the multi-disciplinary team members to develop sustainable best practices that are 
supported by all.   
This project required the collaboration of the long-term care facility and hospice site 
directors and project champions as well as the nursing leadership of both organizations. The LTC 
leadership, medical staff, and nurses were included in education regarding the project 
implementation and were key in the PDSA stages of the project.  During regular rounding at the 
facility, the nursing staff was instrumental in making changes to improve the outcomes.  A 
fellow DNP student and I collaborated on this project.  This collaboration allowed both to 
collaborate with the LTC facility’s leadership team, medical staff, pharmacy staff, and nursing 
staff.  This collaboration allowed focus on both the medical aspect of deprescribing as well as the 
nursing issues surrounding polypharmacy.  Collaboration was important in implementing a 
project that involved the professional stakeholders from multiple disciplines in this quality 
improvement project and thus led to the policy change that was made at this facility.     
Essential VII:  Clinical prevention and population health for improving the nation’s 
health.  Essential VII prepares the DNP graduate to analyze data related to population health 
(AACN, 2006).  As part of this project, scientific data was reviewed related to polypharmacy in 
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the elderly, specifically patients living in long-term care facilities.  A future implication is that 
the DNP nurse will constantly study nursing and related science and use existing knowledge 
related to population health and then commit to relating that knowledge to the population being 
served at the local level.  The DNP will understand how changes in proposed care will affect the 
community, the environment, the culture as well as the larger population.  It is recommended that 
the DNP nurse thinks past the here and now and consider the future of nursing practice.    
Data regarding prescribing cascades, medication-related adverse drug events, and 
readmissions to acute care was also evaluated for this specific population.  The project then 
addressed gaps related to nursing education and confidence regarding recommending 
deprescribing to the provider. This project was designed to share with other long-term care 
facilities, other hospices, the North Carolina State Hospice Association as well as the National 
Hospice and Palliative Care Organization to empower long-term facility staff to consider how 
polypharmacy affects the hospice patient.    
Essential VIII:  Advanced nursing practice.  The DNP prepared nurse is expected to be 
able to design, implement, and assess therapeutic interventions based on nursing sciences as well 
as other sciences (AACN, 2006).  This requires the DNP graduate to demonstrate excellent 
clinical judgment and an ability to collaborate with nurses and other healthcare professionals to 
facilitate optimal patient care and outcomes.  It is recommended that the DNP utilize analytical 
assessment skills to further nursing practice as well as develop collaborative relationships with 
other professionals to foster best practice.  It is also recommended that the DNP nurse uses these 
skills to mentor, foster learning, and support other nurses.  
This project was based on evidence from the nursing, medical and pharmaceutical 
sciences. These sciences provided the necessary knowledge to guide and mentor nursing staff 
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through the project.  The project manager then used analytical skills to assess patient outcomes 
and professional relationships to collaborate with the facility physician, the facility nurse 
practitioner, the facility pharmacist, the facility leadership, and staff nurses to successfully 
implement the project.    
Summary  
The AACN (2006) DNP essentials were used by the project manager to facilitate project 
planning, implementation, and evaluation of the patient outcomes.  This project was based on 
sciences from nursing as well as medicine and pharmacy.  The MedStopper tool was evidence-
based and elements of each DNP essential were used throughout the project. To guide movement 
through the project, the PDSA model ensured that interventions were adapted, and the outcomes 
of the project were met. Adaptations were made to meet the needs of the project’s stakeholders, 
and implications for future utilization were recommended.   
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Chapter Eight:  Final Conclusions 
Polypharmacy presents a challenge to nursing staff caring for patients at the end-of-life.   
The definition of polypharmacy is widely defined but commonly considered five or more 
medications or the use of unnecessary medications. It is common for older adults in the United 
States, with an estimated 50% of people 65 years and older taking more than five medications 
(Reeve et al., 2018). The patient is negatively affected as more and more medications lead to 
increased risk of adverse events, raising the possibility of falls, and increasing the risk of 
emergency department visits (Jokanovic, Tan, Dooley, Kirkpatrick, & Bell, 2015).  The nursing 
staff is negatively affected as increased medications lead to an increased workload for staff 
administering these medications.  Nurses are significant influences on prescribing and 
deprescribing (Ailabouni, Tordoff, Mangin, & Nishtala, 2017).  Education, empowerment, and 
the provision of evidence-based, easy to use tools proved useful for nurses in recommending 
medications for deprescribing.  This chapter discusses the significance of the findings as well as 
the project’s strengths, limitations, benefits, and recommendations for practice.   
Significance of Findings 
  The most significant result was that the data revealed a decrease in at least one drug for 
each patient in one of the drug categories identified.  Successful deprescribing represents nurses 
that felt confident and comfortable in recommending discontinuing medications to the providers 
as well as having discussions with patients and families.  Although fluctuations were noted 
throughout the project period as patients entered and exited the project group, medications in the 
targeted drug categories were routinely deprescribed.  The medication categories most improved 
were antihypertensives with an overall 50% decrease, vitamin/supplements with a 37.5% 
decrease, and gastrointestinal (GI) reflux medications with a 33% decrease.  In a review of the 
REDUCING MEDICATION USE 76 
   
 
average number of targeted drugs per patient, it should be noted that at the onset of the project, 
the per-patient average was 2.46. After the project, the per-patient average had decreased to 1.3 
targeted medications.  None of the patients involved in the project experienced any adverse 
effects from deprescribing medications, and the medications did not need to be restarted after 
being stopped during the project.   
 Positive findings were also the improvement in the nursing staff’s knowledge in 
recognizing polypharmacy and suggesting deprescribing to the providers of the facility.  Of the 
education attendees, 100% indicated a likeliness to use the education presented.  As nurses are 
critical advocates for patients, and being the most knowledgeable about the patients, increasing 
their comfort level is vital in ensuring patient medication regimens are appropriate.   
 The utilization of the MedStopper® tool was defined as taking the MedStopper® report 
to the long-term care (LTC) facility, reviewing the report with the staff, and placing the report on 
the hard copy LTC facility chart.  While a 95% compliance rate was expected the project only 
resulted in a compliance rate of 91%.  It was determined the primary hospice nurse was on 
vacation for a total of six days and the nurse going to the LTC did not utilize the MedStopper® 
tool during the patient visits. 
Project Strength and Limitations 
Several strengths contributed to the success of the project.  One of the key strengths was 
the excellent, long-term relationship between the hospice and the LTC facility. Another strength 
was the resource support of the hospice pharmacy vendor, who was able to provide reports to the 
hospice and the primary project manager.  An additional strength was the collaboration between 
the primary project manager, the hospice nurse practitioner, the hospice nurse visiting in the LTC 
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facility, and the LTC staff.  All working together were key to the project maintaining its 
momentum.  
One limitation of the project was the number of patients involved in the program.  A 
larger sample would have provided more information about the overall deprescribing challenges 
faced by nurses caring for the LTC patient at the end-of-life.  Another significant limitation was 
the impact of the Coronavirus pandemic.  Coronavirus limited the number of times the hospice 
nurse could make patient visits and eliminated the rounding visits being made by the primary 
project manager, making maintaining engagement with the project more challenging.  Also, the 
pandemic contributed to the small patient sample size as the LTC reduced admissions to the 
facility due to the pandemic.     
Project Benefits 
One of the main benefits of this project was the empowerment of the nurses as well as 
providing them with a tool to help them to make deprescribing recommendations.  The 
MedStopper® on-line tool is a simple, free resource nursing staff can use to facilitate a 
discussion about medications with the patient, family members, and providers.  The 
MedStopper® tool provides the nurse with a prioritized list of drugs to be considered for 
deprescribing.  The tool also provides suggestions for tapering, if needed, as well as symptoms 
for nursing staff to be aware of during taper or after discontinuation.   
Recommendations for Practice  
Several recommendations could be put in place based upon the findings of this project.  
The initial intervention was to increase the nurse’s knowledge of polypharmacy and their 
comfort level of suggesting deprescribing. The next step would be to establish on-going 
education regarding polypharmacy and the use of the MedStopper® tool through regular 
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training.  Such training would be beneficial during new nurse orientation and annual training for 
both LTC and hospice nurses.  In addition to education, it would be helpful to continue the 
collaboration between the LTC nurse, the hospice nurse and the hospice nurse practitioner as this 
collaboration allows for nurses to talk through suggestions before approaching the patient, 
family, and provider with a recommendation.   
It is recommended that this project and its findings be shared with the LTC and hospice 
leadership teams to garner support to continue the use of the MedStopper® tool with staff 
periodically.  It is also important to share these outcomes with staff nurses.  As it was the work 
of the staff that led to the project’s success, sharing the findings has the potential to empower the 
nurses to continue to be the voice for the patient as it relates to the medication risks of their 
patients.  Finally, sharing this project’s findings with those outside the project participants has 
the potential to demonstrate how LTC and hospice can work together, using evidence-based tools 
and collaboration to provide the best care for the patient. Suggestions for dissemination are the 
Hospice and Palliative Nurses Association’ Clinical Practice Forum, the National Hospice and 
Palliative Care Organization’s Virtual Interdisciplinary Conference, and the Annual Atrium 
Health Nursing Research Symposium. 
The MedStopper® tool is not specific to only hospice patients residing in LTC facilities 
but rather to all patients who fall into the category of the frail, elderly. Thus, this tool could be 
utilized for any patient considered frail and elderly regardless of prognosis or location of care.  
This tool could be used throughout healthcare to assist all professional caregivers in making the 
best decisions about when to discontinue medications.  Sharing this project and its results 
through a journal submission such as The Hospice and Palliative Nursing Journal has the 
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opportunity for many to see the benefits of using a tool to identify medications that may be 
deprescribed.    
Final Summary 
 Medications are the key to excellent care of patients at the end-of-life, and while most 
medications are prescribed with a reasonable indication, when to deprescribe medications is a 
topic not often considered.  Not considering stopping medications can easily lead to a prescribing 
cascade and polypharmacy; thus, leading to increased risk of adverse drug events, increased risk 
for falls, the potential for non-compliance, and additional burden on LTC nursing staff providing 
care.  Educating and empowering nurses in recognizing polypharmacy as well as how to 
recommend deprescribing to providers is key to successful medication management.  Education 
and easy to use tools to guide decision-making and increase the confidence of the nurse can lead 
to more engagement in assisting the provider in making the right medication decisions.  With the 
information discovered through this evidence-based quality improvement project, it is essential 
to note that the appropriate management of medications is considered necessary in maintaining a 
satisfactory quality of life in the hospice patient.  Engagement and collaboration combined with 
education and evidence-based tools can ensure the best care is provided, and overall, that is the 
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Appendix B 
Plan, Do, Study Act (PDSA) Model 
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Appendix D 
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Appendix E 
DNP Project Budget 
Item Unit Cost Quantity Total Cost 
Paper $0.03 500 $15.00 
Ink cartridge $30.00 1 $30.00 
Snack food N/A N/A $50.00 
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Appendix F 
Atrium IRB Approval Document 
QI vs Research Form 
 
* All fields on this form are required to be completed before submitting * 
 
* Do not submit this form for projects already completed. Contact the IRB at IRBlnfo@atriumhealth.org * 
 
 






Institutional Review Board/ Patient Privacy Board 
 
IRB Review & Determination of QI vs. Research Projects 
Submission Date: 11-06-2019 
 














Phone: [site phone number] 
 
E-mail: [lead email address] 
Project Title: Reducing Medication Use in 




Purpose of the project: 
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(Provide a 2-3 sentence description.) 
The outcome is to increase hospice and long-term care nursing knowledge regarding 
polypharmacy, identifying medications that may be stopped, and how to recommend deprescribing 
to the provider. This is not new knowledge but rather knowledge not frequently discussed. The 
aim is to evaluate whether education and the use of a standardized tool can result in a decrease in 
medications in the hospice patient in targeted drug categories. 
 
Briefly describe project details, including how patients and/or providers will 
be involved: (Provide a 2-3 sentence description.) 
Project methods will include: education of hospice and [SNF site] nursing staff, hospice 
implementation of the online MedStopper tool, and weekly review of hospice charts and hospice 
pharmacy vendor reports. Additional education may be provided to nursing staff according to the 
PDSA model as a result of chart review 
Signatures 
 
CERTIFICATION OF PROJECT LEAD: 
 
I certify that the information provided in this IRB Review of QI and Research Projects screening form is complete 
and accurate. The above titled project has been/will be conducted in full compliance with the HHS/FDA 
Regulations and IRB requirements/policies governing human subject research. IRB review is required for 
projects meeting the criteria of, "Research" as noted above. 
 
Signature of Project Lead: 
 












Forward to which chair? [chair name ] 
 
Date: 11-11-2019 15:57:22 




Require edits or changes?  No 
 
The IRB has determined this project is:  Quality Improvement 
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Completed By: [QI name here] 
((Please Print Full Name)) 
 
IRB Chair Signature 
        [IRB Signature here] 
 
 
Date: 11-14-2019 06:26:37 
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Appendix G 
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Appendix H 
Education Flyer  
 
POLYPHARMACY 
In the hospice patient 
Come learn about what it is, 
how to recognize it, and how to 
talk with the provider about it! 
WHO?     All medication staff                                                                                                      
When?   January 14 2pm 
                 January 16 2pm 
                 January 20 2pm 
                 January 24 2pm 
Where? The Solarium  
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Appendix I 
Pre-Education Nursing Staff Survey 
Program Title: Polypharmacy in the Hospice Patient Residing in the LTC Facility  
Date:              
 
Please circle your answers 
1. What is your role? LPN    RN     RN Supervisor 
 
2. How many years have you worked in long-term care?      
< 1 year        2-5 years          5-10 years          >10 years 
 
3. How comfortable would you say you are in recognizing polypharmacy? 
Very uncomfortable          Uncomfortable          Comfortable       Very Comfortable 
 
4. How comfortable would you say you are in suggesting deprescribing a medication to 
the provider? 
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Appendix J 
Post-Education Nursing Staff Survey 
Program Title: Polypharmacy in the Hospice Patient Residing in the LTC Facility  
Date:              
 
Please circle your answers 
1. What is your role? LPN       RN   RN Supervisor 
2. How many years have you worked in long-term care?      
< 1 year        2-5 years          5-10 years          >10 years 
3. How comfortable would you say you are in recognizing polypharmacy? 
Very uncomfortable          Uncomfortable          Comfortable       Very Comfortable 
4. How comfortable would you say you are in suggesting deprescribing a medication to 
the provider? 
Very uncomfortable          Uncomfortable          Comfortable       Very Comfortable 
5. How likely are you to use any of the information provided today in your daily 
practice? 
Very unlikely      Unlikely  Likely  Very Likely 
If not likely, please state why:        
             
6. What specifically did you learn today that you intend to use in your daily practice? 
(Please be as specific as possible)         
            
            
             
7. What do you wish you had learned more about during today’s presentation? (Please 
be as specific as possible).          
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Appendix K 
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Appendix L 
Permission to use MedStopper® Tool 
Re: Permission to use request 
Alan Cassels <email address> 
Thu 10/10/2019 05:23 PM 
To: 
•  Long, Lee Ann <longlee18@students.ecu.edu> 
Yes, go ahead. Let me know how it goes.  
 





office [phone number] 
cell [phone number] 
  
 
From: Long, Lee Ann <longlee18@students.ecu.edu> 
Sent: October 10, 2019 2:06 PM 
To: [email address] 
Subject: Permission to use request 
  
To Whom it May Concern: 
 
My name is Lee Ann Long, I am a doctoral student enrolled in the East Carolina University 
College of Nursing.  I am conducting a doctor of nursing practice (DNP) quality improvement 
project regarding polypharmacy and deprescribing in the hospice patient residing in the long-
term care setting.  I discovered your online tool, MedStopper® through my research on the 
topic and found it extremely easy to use.   
 
 I would like to request your permission to use your tool in the education of nursing staff 
participating in our project.   
 
Thank you so very much for your tool and for your response. 
 
Lee Ann Long, MSN, RN, CHPN 
East Carolina University 
College of Nursing DNP Student 
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Appendix M 
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Appendix N 
MedStopper® Compliance Tool 
MedStopper® Initial and Weekly Compliance Tool 
          
Yes = Tool discussion was documented in hospice clinical note 
No = Tool discussion was not documented in hospice clinical note 
          
Patient # Initial  Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8  
1                   
2                   
3                   
4                   
5                   
6                   
7                   
8                   
9                   
10                   
11                   
12                   
13                   
14                   
15                   
16                   
17                   
18                   
19                   
20                   
21                   
22                   
23                   
24                   
25                   
26                   
27                   
28                   
29                   
30                   
31                   
32                   
33                   
34                   
35                   
36                   
37                   
38                   
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Targeted Drug Class Data Collection Tool 








Enhancing drugs Antihypertensives 
Diabetic 
Medications 
1             
2             
3             
4             
5             
6             
7             
8             
9             
10             
11             
12             
13             
14             
15             
16             
17             
18             
19             
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Appendix P 

























INITIAL WEEK 1 WEEK 2 WEEK 3 WEEK 4 WEEK 5 WEEK 6 WEEK 7 WEEK 8 WEEK 9 WEEK 10 WEEK11 WEEK 12
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Appendix Q 















Initial 8 9 0 4 0 10 1 
1 5 7 0 1 0 7 1 
2 6 7 0 2 0 8 4 
3 6 7 0 2 0 8 4 
4 5 6 0 2 0 7 3 
5 8 6 0 2 0 5 3 
6 10 8 0 3 0 8 2 
7 7 8 0 3 0 8 2 
8 7 7 0 3 0 9 4 
9 5 6 0 2 0 6 0 
10 5 7 1 2 0 4 0 
11 2 5 0 2 0 4 0 
12 3 3 0 2 0 5 0 
          
 
 
 
 
 
 
 
 
 
 
 
